<SEC-DOCUMENT>0000950170-24-100065.txt : 20240823
<SEC-HEADER>0000950170-24-100065.hdr.sgml : 20240823
<ACCEPTANCE-DATETIME>20240823115646
ACCESSION NUMBER:		0000950170-24-100065
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240702
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240823
DATE AS OF CHANGE:		20240823

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arcadia Biosciences, Inc.
		CENTRAL INDEX KEY:			0001469443
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE PRODUCTION - CROPS [0100]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				810571538
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37383
		FILM NUMBER:		241234879

	BUSINESS ADDRESS:	
		STREET 1:		202 COUSTEAU PLACE
		STREET 2:		SUITE 105
		CITY:			DAVIS
		STATE:			X1
		ZIP:			95618
		BUSINESS PHONE:		530-756-7077

	MAIL ADDRESS:	
		STREET 1:		202 COUSTEAU PLACE
		STREET 2:		SUITE 105
		CITY:			DAVIS
		STATE:			CA
		ZIP:			95618
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>rkda-20240702.htm
<DESCRIPTION>8-K/A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-08-23T11:32:53.6259+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:rkda="http://arcadiabio.com/20240702" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K/A</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_781c6cc3-d85e-4dee-a71c-5d3f4c44b185" name="dei:EntityCentralIndexKey" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6">0001469443</ix:nonNumeric><ix:nonNumeric id="F_71c7ccda-c00a-48c7-a360-be29af2701e4" name="dei:AmendmentFlag" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6">true</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="rkda-20240702.xsd"/></ix:references><ix:resources><xbrli:context id="C_58bd9847-8f56-4853-b412-803a645ebfd6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001469443</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-02</xbrli:startDate><xbrli:endDate>2024-07-02</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="min-height:0.5in;"></div>
  <p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c684eee7-1c24-4a08-b14f-1fbd6bf39fcd" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">8-K/A</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Amendment No. 1)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_297a0114-b3b9-464b-871b-d9ce87775838" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">July 02, 2024</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3899828b-edb2-4bab-bde3-5d2994278a8c" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;">Arcadia Biosciences, Inc.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20%;"/>
    <td style="width:1%;"/>
    <td style="width:20%;"/>
    <td style="width:18%;"/>
    <td style="width:41%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_bb860665-a4c0-41c6-bec5-b24f54894f40" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_135604ac-9352-49b9-aaf2-102d90fd3201" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">001-37383</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_0299b415-ecb2-43b0-93ff-72bcf58f9301" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">81-0571538</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_6cf74e26-d5b4-45cf-9278-d454400b2888" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">5950 Sherry Lane</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_26f7b18d-bcdd-4a2e-bf06-25640a727b35" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Suite 215</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9ff841ca-d852-4d75-b71e-7cd932c19795" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Dallas</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_5f9dda79-d010-4490-9cc6-78222e123713" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Texas</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_6a6d766f-eb0a-42df-b0ba-a85fc060fb86" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">75225</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_ef7d22aa-988b-4112-975f-2513c0ce4182" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">214</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_ff76eeb3-80f9-47f6-8842-64b9dc576431" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">974-8921</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_03937203-09c9-4260-b869-4c0cf6f58631" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_481e5f9d-3a45-449f-b64d-3e3b1d2ac87d" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6f7653e9-0d5e-4cd4-b823-a3cac8c31dc0" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_47d0094b-32bf-447d-b4d6-38608c749273" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38%;"/>
    <td style="width:1%;"/>
    <td style="width:15%;"/>
    <td style="width:1%;"/>
    <td style="width:45%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Title of each class</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_00e8ed8e-489d-426d-bf1e-c2a35ec4ddb7" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Common</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_17b3a4f9-c9fc-421d-b7bb-8a56aba6822d" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">RKDA</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_562d0bbd-6ed5-46e6-8b1a-2d4c9039d607" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_c62bcb26-536b-499d-8dac-0ad30cad5c70" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Explanatory Note</span></p>
  <p style="font-size:10pt;margin-top:3.6pt;font-family:Times New Roman;margin-bottom:3.6pt;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_71215fe3-c58a-48d1-af60-b4d3da539c3b" contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6" name="dei:AmendmentDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On July 8, 2024, Arcadia Biosciences, Inc. (the &#8220;Company&#8221;) filed a Current Report on Form 8-K (&#8220;Original Form 8-K&#8221;) to report, among other things, the appointment of Thomas J. Schaefer as the Company&#8217;s chief executive officer and Mark Kawakami as the Company&#8217;s chief financial officer, effective July 5, 2024 (&#8220;Effective Date&#8221;).  The Company is filing this Form 8-K/A to amend the Original Form 8-K to disclose new compensation information for Mr. Schaefer and Mr. Kawakami in connection with their appointments.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On August 20, 2024, the Company and Mr. Schaefer entered into an employment terms letter (the &#8220;Schaefer Employment Letter&#8221;) that establishes his base salary as of the Effective Date as $260,000 per annum and his 2024 target bonus opportunity as 40% of his base salary for the portion of 2024 he served as the Company&#8217;s chief financial officer and 50% of his base salary for the portion of 2024 that he serves as the Company&#8217;s chief executive officer.  As set forth in the Schaefer Employment Letter, and consistent with the Company&#8217;s other named executive officers, Mr. Schaefer&#8217;s employment is &#8220;at-will.&#8221;  Mr. Schaefer has entered into a severance and change in control agreement with the Company (the &#8220;Schaefer CIC Agreement&#8221;), which by its terms will expire on the third anniversary of the Effective Date.  Pursuant to the Schaefer CIC Agreement, if the Company terminates Mr. Schaefer&#8217;s employment for a reason other than cause or Mr. Schaefer&#8217;s death or disability at any time other than during the twelve-month period immediately following a change of control, then Mr. Schaefer will receive the following severance benefits from the Company:  (i) severance in the form of base salary continuation for a period of six months; (ii) reimbursement for premiums paid for coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, or COBRA, for Mr. Schaefer and his eligible dependents for up to six months; and (iii) a pro-rated portion of the annual cash bonus he would have been entitled to receive for the year of termination if he had remained employed by the Company through the end of such year.</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If during the twelve-month period immediately following a change of control, (x) the Company terminates Mr. Schaefer&#8217;s employment for a reason other than cause or Mr. Schaefer&#8217;s death or disability, or (y) Mr. Schaefer resigns from employment for good reason, then, in lieu of the above described severance benefits, Mr. Schaefer shall receive the following severance benefits from the Company:  (i) severance in the form of base salary continuation for a period of twelve months; (ii) reimbursement for premiums paid for coverage pursuant to COBRA for Mr. Schaefer and his eligible dependents for up to twelve months; (iii) a pro-rated portion of the annual cash bonus he would have been entitled to receive for the year of termination if he had remained employed by the Company through the end of such year; and (iv) vesting shall accelerate as to 100% of all of Mr. Schaefer&#8217;s outstanding equity awards.</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On August 20, 2024, the Company and Mr. Kawakami entered into an employment terms letter (the &#8220;Kawakami Employment Letter&#8221;, and together with the Schaefer Employment Letter, the &#8220;Employment Letters&#8221;) that establishes his base salary as of the Effective Date as $212,063 per annum and his 2024 target bonus opportunity as 20% of his base salary for the portion of 2024 he served as the Company&#8217;s vice president of finance and 30% of his base salary for the portion of 2024 that he serves as the Company&#8217;s chief financial officer.  As set forth in the Employment Letter, and consistent with the Company&#8217;s other named executive officers, Mr. Kawakami&#8217;s employment is &#8220;at-will.&#8221;  Mr. Kawakami has entered into a severance and change in control agreement with the Company (the &#8220;Kawakami CIC Agreement&#8221;, and together with the Schaefer CIC Agreement, the &#8220;CIC Agreements&#8221;), which by its terms will expire on the third anniversary of the Effective Date.  Pursuant to the Kawakami CIC Agreement, if the Company terminates Mr. Kawakami&#8217;s employment for a reason other than cause or Mr. Kawakami&#8217;s death or disability at any time other than during the twelve-month period immediately following a change of control, then Mr. Kawakami will receive the following severance benefits from the Company:  (i) severance in the form of base salary continuation for a period of six months; (ii) reimbursement for premiums paid for coverage pursuant to COBRA for Mr. Kawakami and his eligible dependents for up to six months; and (iii) a pro-rated portion of the annual cash bonus he would have been entitled to receive for the year of termination if he had remained employed by the Company through the end of such year.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If during the twelve-month period immediately following a change of control, (x) the Company terminates Mr. Kawakami&#8217;s employment for a reason other than cause or Mr. Kawakami&#8217;s death or disability, or (y) Mr. Kawakami resigns from employment for good reason, then, in lieu of the above described severance benefits, Mr. Kawakami shall receive the following severance benefits from the Company:  (i) severance in the form of base salary continuation for a period of twelve months; (ii) reimbursement for premiums paid for coverage pursuant to COBRA for Mr. Kawakami and his eligible dependents for up to twelve months; (iii) a pro-rated portion of the annual cash bonus he would have been entitled to receive for the year of termination if he had remained employed by the Company through the end of such year; and (iv) vesting shall accelerate as to 100% of all of Mr. Kawakami&#8217;s outstanding equity awards.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On August 19, 2024, the Company granted Mr. Schaefer and Mr. Kawakami stock options under the Company&#8217;s 2015 Omnibus Equity Incentive Plan (&#8220;Stock Options&#8221;).  Each of Mr. Schaefer and Mr. Kawakami were granted Stock Options to purchase 20,000 shares of the Company&#8217;s common stock with an exercise price of $2.71 per share.  Mr. Schaefer&#8217;s and Mr. Kawakami&#8217;s right to exercise the Stock Options vests over four years (25% on the one-year anniversary of the grant date, with the remaining 75% vesting in 36 equal monthly installments thereafter), subject to the applicable executive continuing to provide service to the Company on each vesting date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The foregoing descriptions of the Employment Letters and CIC Agreements are a summary and are qualified in their entirety by reference to the Employment Letters and appended forms of CIC Agreements, which are attached hereto as Exhibits 10.1 and 10.2 and incorporated by reference herein.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9%;"/>
    <td style="width:1%;"/>
    <td style="width:90%;"/>
   </tr>
   <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:1pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Exhibit No.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:1pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:1pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:6pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.1+</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="rkda-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Employment Letter and Severance and Change In Control Agreement for Thomas J. Schaefer.</span></a></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.2+</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="rkda-ex10_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Employment Letter and Severance and Change In Control Agreement for Mark Kawakami.</span></a></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">+ </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Represents a compensatory plan or arrangement.</span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNATURES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6%;"/>
    <td style="width:44%;"/>
    <td style="width:4%;"/>
    <td style="width:46%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">ARCADIA BIOSCIENCES, INC.</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">August 23, 2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ MARK KAWAKAMI</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Mark Kawakami, Chief Financial Officer</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>rkda-ex10_1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html>
 <head>
  <title>EX-10.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="min-height:0.9in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img5370606_0.jpg" alt="img5370606_0.jpg" style="width:194px;height:138px;">&#160;</p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">August 20, 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Thomas Schaefer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">[Address]</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Dear Thomas:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">This letter sets forth the terms of your employment as Chief Executive Officer of Arcadia Biosciences, Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), a position you have held since July 5, 2024 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Effective Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). The terms set forth below shall be effective as of the Effective Date.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Title and Base Salary</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  You will report directly to the Company&#x2019;s Board of Directors.  Beginning on the Effective Date, your annual base salary shall be $260,000.  The salary shall be subject to an annual review and may be increased at the discretion of the Company&#x2019;s Board of Directors.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Bonus Compensation</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  In addition to your base salary, you will be eligible for an annual incentive cash bonus, as determined by the Company. For calendar year 2024, your annual incentive cash bonus shall have a target equal to 50% of your base salary as of the Effective Date, prorated for the portion of 2024 during which you are employed by the Company as the Company&#x2019;s Chief Executive Officer, and 40% of your base salary immediately before your appointment as the Company&#x2019;s Chief Executive Officer, prorated for the portion of 2024 during which you were employed as the Company&#x2019;s Chief Financial Officer.  The target bonus and its components, the Company performance goals, and your individual objectives shall be determined and documented each year by the Compensation Committee of the Board of Directors (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Compensation Committee</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Vacation</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  You will be entitled to four (4) weeks of paid vacation for each calendar year.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Equity Awards</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:11.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.111%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Company may grant equity awards to you from time to time, which will be subject to the terms of the applicable equity compensation plan or arrangement in effect at the time of grant. The Compensation Committee will determine in its discretion whether you will be granted any such equity awards and the terms and conditions of any such awards in accordance with the terms of any applicable equity plan. You should be aware that you may incur federal and state income taxes as a result of your receipt, or the vesting of any equity compensation awards and it shall be your responsibility to pay any such applicable taxes.</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Severance and Change in Control Agreement</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  You will have the benefits set forth in a Severance and Change in Control Agreement between you and the Company to be executed on the date of this letter and to be effective as of the Effective Date, a copy of which is attached hereto (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Severance Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.657%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Other Benefits</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">You will be eligible for all Company adopted benefits, under the terms and conditions of such benefit plans.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Your employment is &#x201c;at-will,&#x201d; which means that either you or the Company may terminate the employment relationship at any time for any reason or for no reason (subject to the terms of the Severance Agreement). This at-will relationship may not be modified by any oral or implied agreement.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Confidentiality Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  As a condition to you continuing employment with the Company, you will execute on the date of this letter the Company&#x2019;s Confidentiality and Invention Assignment Agreement, a copy of which is attached hereto (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Confidentiality Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">This letter, the Severance Agreement, the Confidentiality Agreement, and any policies that the Company may adopt from time to time constitute the entire agreement relating to the terms of your employment with the Company.  Please sign, date and return this letter to the Company to acknowledge the terms hereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">If you should have any questions, please feel free to call me.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Sincerely,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">/s/ KEVIN COMCOWICH</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Kevin Comcowich</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Chairman of the Board</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ACCEPTED BY:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">/s/ THOMAS SCHAEFER</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Thomas Schaefer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">August 20, 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">August 20, 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img5370606_1.jpg" alt="img5370606_1.jpg" style="width:195px;height:138px;">&#160;</p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.38%;text-align:center;"><font style="color:#2b2b2b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">SEVERANCE </font><font style="color:#3b3b3b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">AND </font><font style="color:#2b2b2b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">CHANGE IN CONTROL AGREEMENT</font></p>
  <p style="text-indent:6.769%;font-size:10pt;margin-top:12.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.315%;text-align:justify;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">This Severance and Change in Control Agreement (the </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#3b3b3b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Agreement</font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">is made and entered into by and between Thomas J. Schaefer (&#x201c;</font><font style="color:#2b2b2b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive</font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;)</font><font style="color:#2b2b2b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and Arcadia Biosciences, Inc. (the &#x201c;</font><font style="color:#2b2b2b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Company</font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;),</font><font style="color:#2b2b2b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">effective as of July 5, 2024 (the </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#3b3b3b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Effective </font><font style="color:#2b2b2b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Date</font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></p>
  <p style="margin-left:1.773%;font-size:10pt;margin-top:11.75pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.38%;text-align:center;"><font style="color:#2b2b2b;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">RECITALS</font></p>
  <div class="item-list-element-wrapper" style="text-indent:6.748%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.204%;min-width:6.667%;text-align:justify;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Compensation Committee of the Board of Directors of the Company (the </font><font style="color:#4f4f4f;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#4f4f4f;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Committee</font><font style="color:#4f4f4f;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#4f4f4f;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">recognizes that it is possible that the Company could terminate Executive&#x2019;s at-will employment with the Company and from time to time the Company may consider the possibility of an acquisition by another company or other change in control transaction. The Committee also recognizes that such considerations can be a distraction to Executive and can cause Executive to consider alternative employment opportunities. The Committee has determined that it is in the best interests of the Company and its stockholders to assure that the Company </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">will </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">have the continued dedication and objectivity of Executive, notwithstanding the possibility, threat or occurrence of such a termination of employment or the occurrence of a Change in </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Control </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(as defined herein) of the Company.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.748%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.204%;min-width:6.667%;text-align:justify;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Committee believes that it is in the best interests of the Company and its stockholders to provide </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive with </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">an incentive to continue his employment </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">with </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Company and to motivate Executive to maximize </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the value </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">of the Company for </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">benefit of its stockholders.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.748%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.204%;min-width:6.667%;text-align:justify;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Committee believes that it is imperative to provide Executive with certain severance benefits upon </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">termination of employment and with certain additional benefits following a Change in </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Control. These </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">benefits </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">will </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">provide </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">with enhanced financial security and incentive and encouragement to remain with the </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Company </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">notwithstanding the possibility of </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">a </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Change in Control.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.748%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.204%;min-width:6.667%;text-align:justify;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Company </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">have entered into </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">an </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">employment terms letter dated August 20, 2024 and made effective as of July 5, 2024 (the </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#3b3b3b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Employment Letter</font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#3b3b3b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">).</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.738%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Company and Executive entered into a Severance and Change in Control Agreement, effective as of January 3, 2023 (&#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Prior Agreement</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).  This Agreement amends and restates the Prior Agreement in its entirety.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.738%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Company and Executive wish to restate the terms of Executive&#x2019;s severance </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and benefits (whether or not in connection with a Change in Control) and replace any and all such provisions providing for severance and/or change in control payments, as set forth below. All other terms and conditions of the Employment Letter will remain in full force and effect.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Certain capitalized terms used in the Agreement are defined in Section 6</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">below.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">AGREEMENT</font></p>
  <p style="text-indent:6.68%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows:</font></p>
  <div class="item-list-element-wrapper" style="text-indent:6.738%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Term of Agreement</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Agreement shall terminate on the third (3</font><font style="color:#2d2d2d;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;min-width:fit-content;">rd</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) anniversary of the Effective Date (the &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Term End Date</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">); </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">provided, however, that if as of the Term End Date Executive is receiving benefits under Section 3 of this Agreement, then the Agreement shall continue in effect until such date as all of the obligations of the parties hereto with respect to this Agreement have been satisfied.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.738%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">At-Will Employment</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Company and Executive acknowledge that, notwithstanding this Agreement and any benefits provided for herein, Executive&#x2019;s employment is and will continue to be at-will, as defined under applicable law. If Executive&#x2019;s employment terminates for any reason, including (without limitation) any termination of employment not set forth in Section 3, Executive will not be entitled to any payments, benefits, damages, awards or compensation other than the payment of accrued but unpaid wages and vacation, if any, as required by law, and any unreimbursed reimbursable expenses or pursuant to written agreements with the Company, including equity award agreements.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Severance Benefits.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.477%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination without Cause and not in Connection with a Change in Control.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> If the Company terminates Executive&#x2019;s employment with the Company for a reason other than Cause, Executive becoming Disabled, or Executive&#x2019;s death, at any time other than during the twelve (12)-month period immediately following a Change in Control, then, subject to Section 4, Executive will receive the following severance benefits from the Company:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;text-indent:20.787%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20.398%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:1.4838111366477158%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Accrued Compensation.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> The Company will pay Executive all accrued but unpaid vacation, expense reimbursements, wages, and other benefits due to Executive under any Company-provided plans, policies, and arrangements.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;text-indent:20.243%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:19.87%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.0160477400104835%;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Severance Payment.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive will receive continuing payments of severance for a period of six (6) months (such number of months, the &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Standard Severance Period</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">from the date of such termination of employment at a rate equal to Executive&#x2019;s base salary as in effect immediately prior to the date of Executive&#x2019;s termination of employment (disregarding any reduction in base salary that triggers the right to termination for Good Reason), less all required tax withholdings and other applicable deductions</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">which will be paid in accordance with the Company</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s regular payroll procedures.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;text-indent:19.672%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.602%;min-width:19.204%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.6883996613039796%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Continued Employee Benefits.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> If Executive elects continuation </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.602%;min-width:19.204%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">as amended </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">COBRA</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">for Executive and Executive</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s eligible dependents</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">within the time period prescribed pursuant to COBRA, the Company will reimburse Executive for the COBRA premiums for such coverage (at the coverage levels in effect immediately prior to Executive&#x2019;s termination or resignation) until the earlier of (A) the end of the Standard Severance Period, or (B) the date upon which Executive and</font><font style="color:#5d5d5d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">/</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">or Executive</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s eligible dependents becomes covered under similar plans. COBRA reimbursements will be made by the Company to Executive consistent with the Company&#x2019;s normal expense reimbursement policy and will be </font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">t</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">axable to the extent required to avoid adverse consequences to Executive or the Company under either Code Section 105(h) or the Patient Protection and Affordable Care Act of 2010.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pro-Rated Bonus.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Following the end of the year in which Executive&#x2019;s employment with the Company terminates</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">but no later than March 15 of such following year</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Committee, and if applicable</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Company</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s Board of Directors </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Board</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">), </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">shall determine in good faith the annual cash bonus that Executive would have been entitled to receive for the year of termination if Executive had remained employed by the Company through the end of such year (such hypothetical bonus, the </font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination Year Bonus</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">). </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Company will pay Executive a pro-rated portion of the Termination Year Bonus based on the percentage of the year that Executive was employed by the Company in the year of termination. This amount will be payable on or before the earlier of (i) March 15 of the year immediately following the year of Executive&#x2019;s termination and (ii) the date that the Company pays annual cash bonuses to other executives of the Company with respect to the year of </font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">E</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">xecutive</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s termination</font><font style="color:#111111;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;text-indent:20.411%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:19.87%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.0160477400104835%;text-indent:0;display:inline-flex;justify-content:flex-start;">(v)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Payments or Benefits Required by Law.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive will receive such other compensation or benefits from the Company as may be required by law.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.587%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination without Cause or Resignation for Good Reason in Connection with a Change in Control.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> If during the twelve (12)-month period immediately following a Change in Control, (x) the Company terminates Executive&#x2019;s employment with the Company for a reason other than Cause</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive becoming Disabled, or Executive&#x2019;s death</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">or (y) Executive resigns from such employment for Good Reason, then</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">subject to Section 4</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive will receive the following severance benefits from the Company in lieu of the benefits described in Section 3(a) above:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Accrued Compensation.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> The Company will pay Executive all accrued but unpaid vacation, expense reimbursements</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">wages</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and other benefits due to Executive under any Company-provided plans, policies, and arrangements.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Severance Payment.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive will receive continuing pa</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ments of severance for a period of twelve (12) months (such number of months</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Enhanced Severance Period</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">from the date of such termination of employment at a rate equal to Executive&#x2019;s base salary as in effect immediately prior to the date of Executive&#x2019;s termination of employment (disregarding any reduction in base salary that triggers the right to termination for Good Reason), less all required tax withholdings and other applicable deductions, which will be paid in accordance with the Company&#x2019;s regular payroll procedures.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Continued Employee Benefits.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> If Executive elects continuation coverage pursuant to COBRA for Executive and Executive</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s eligible dependents</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">within the time period prescribed pursuant to COBRA</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Company will reimburse Executive for the </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">COBRA premiums for such coverage (at the coverage levels in effect immediately prior to Executive&#x2019;s termination or resignation) until the earlier of (A) the end of the Enhanced Severance Period</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">or (B) the date upon which Executive and/or Executive&#x2019;s eligible dependents becomes covered under similar plans. COBRA reimbursements will be made by the Company to Executive consistent with the Company&#x2019;s normal expense reimbursement policy and will be taxable to the extent required to avoid adverse consequences to Executive or the Company under either Code Section 105(h) or the Patient Protection and Affordable Care Act of 2010.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Equity.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive will be entitled to accelerated vesting as to one hundred percent (100%) of the then-unvested portion of all of </font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">E</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">xecutive&#x2019;s outstanding equity awards.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(v)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pro-Rated Bonus.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Following the end of the year in which Executive&#x2019;s employment with the Company terminates</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">but no later than March 15 of such following year, the Committee</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and if applicable, the Board</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">shall determine in good faith the Termination Year Bonus (as defined above). The Compan</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">will pa</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive a pro&shy; rated portion of the Termination Year Bonus based on the percentage of the year that Executive was employed by the Company in the year of termination. This amount will be payable on or before the earlier of (i) March 15 of the year immediately following the year of Executive&#x2019;s termination and (ii) the date that the Company pays annual cash bonuses to other executives of the Company with respect to the year of Executive</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s termination.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(vi)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Payments or Benefits Required by Law</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive will receive such other compensation or benefits from the Company as may be required by law.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.587%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Disability; Death</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">If Executive</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s employment with the Company is terminated due to Executive becoming Disabled or Executive</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s death</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">then </font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">E</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">xecutive or Executive&#x2019;s estate (as the case may be) will (i) receive the earned but unpaid base salary through the date of termination of employment</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(ii) receive all accrued vacation, expense reimbursements and any other benefits due to Executive through the date of termination of employment in accordance with Company-provided or paid plans, policies and arrangements, and (iii) not be entitled to any other compensation or benefits from the Company except to the extent required by law (for example</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">COBRA)</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.587%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Voluntary Resignation</font><font style="color:#484849;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">; </font><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination for Cause.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> If Executive voluntarily terminates Executive</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s employment with the Company (other than for Good Reason following a Change in Control) or if the Company terminates Executive&#x2019;s employment with the Company for Cause, then Executive will (i) receive his or her earned but unpaid base salary through the date of termination of employment, (ii) receive all accrued vacation, expense reimbursements and any other benefits due to Executive through the date of termination of employment in accordance with established Company-provided or paid plans, policies and arrangements, and (iii) not be entitled to any other compensation or benefits (including, without limitation, accelerated vesting of any equity awards) from the Company except to the extent provided under agreement(s) relating to any equity awards or as may be required by law (for example, COBRA).</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.587%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Timing of Payments.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Subject to Section 4, payment of the severance and benefits hereunder shall be made or commence to be made as soon as practicable following Executive&#x2019;s termination of employment.</font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="text-indent:13.587%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:13.333%;text-align:justify;"><font style="color:#464646;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#464646;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exclusive </font><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Remedy.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> In the event of a termination of Executive&#x2019;s employment with the Company pursuant to Section 3(a) or Section 3(b), the provisions of this Section 3 are intended to be and are exclusive and in lieu of any other rights or remedies to which Executive or the Company may otherwise be entitled, whether at law, tort or contract, in equity, or under this Agreement (other than the payment of accrued but unpaid wages, as required by law, and any unreimbursed reimbursable expenses). Executive will be entitled to no other severance, benefits, compensation or other payments or rights upon a termination of employment, including, without limitation, any severance payments and/or benefits provided in the Employment Agreement, other than those benefits expressly set forth in Section 3 of this Agreement or pursuant to written equity award agreements with the Company. </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Conditions to Receipt of Severance.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Release of Claims Agreement.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> In the event of a termination of </font><font style="color:#464646;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">employment with the Company pursuant to Section 3(a) or Section 3(b), the receipt of any severance payments or benefits pursuant to this Agreement is subject to </font><font style="color:#464646;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">signing and not revoking a separation agreement and release of claims in a form acceptable to the Company (the &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Release</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">), </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">which must become effective no later than the sixtieth (60</font><font style="color:#2d2d2d;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) day following Executive&#x2019;s termination of employment (the </font><font style="color:#464646;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#464646;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Release </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Deadline</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">), </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and if not, Executive will forfeit any right to severance payments or benefits under this Agreement. </font><font style="color:#464646;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">To </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">become effective</font><font style="color:#5d5d5d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Release must be executed by Executive and any revocation periods (as required by statute, regulation, or otherwise) must have expired without Executive having revoked the Release. In addition, in no event will severance payments or benefits be paid or provided until the Release actually becomes effective. If the termination of employment occurs at a time during the calendar year where the Release Deadline could occur in the calendar year following the calendar year in which Executive&#x2019;s termination of employment occurs, then any severance payments or benefits under this Agreement that would be considered Deferred Payments (as defined in Section 4(d)(i)) will be paid on the first payroll date to occur during the calendar year following the calendar year in which such termination occurs, or such later time as required by (i) the payment schedule applicable to each payment or benefit as set forth in Section 3, (ii) the date the Release becomes effective, or (iii) Section 4(d)(ii); provided that the first payment </font><font style="color:#232324;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">shall include all amounts that would have been paid to Executive if payment had commenced on the date of Executive&#x2019;s termination of employment.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.605%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.333%;text-align:justify;"><font style="color:#232324;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#232324;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Confidential Information Agreement and Other Requirements.</font><font style="color:#232324;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive&#x2019;s receipt of any payments or benefits under Section 3 (except for those required by law) will be subject to Executive continuing to comply with the terms of the Confidential Information Agreement (as defined in Section 9) executed by Executive in favor of the Company and the provisions of this Agreement.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#232324;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#232324;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 409A.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notwithstanding anything to the contrary in this Agreement, no severance pay or benefits to be paid or provided to Executive, if any, pursuant to this Agreement that, when considered together with any other severance payments or separation benefits, are considered deferred compensation not exempt under Section 409A (together, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Deferred Payments</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">will be paid or otherwise provided until Executive has a &#x201c;separation from service&#x201d; within the meaning of Section 409A. And for purposes of this Agreement, any reference to &#x201c;termination of employment,&#x201d; &#x201c;termination&#x201d; or any similar term shall be construed to mean a </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:20%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;separation from service&#x201d; within the meaning of Section 409A. Similarly</font><font style="color:#444444;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">no severance payable to Executive, if any, pursuant to this Agreement that otherwise would be exempt from Section 409A pursuant to Treasury Regulation Section 1.409A-1(b)(9) will be payable until Executive has a &#x201c;separation from service&#x201d; within the meaning of Section 409A.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.352%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notwithstanding anything to the contrary in this Agreement, if Executive is a </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;specified </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">employee&#x201d; within the meaning of Section 409A at the time of Executive&#x2019;s termination of employment (other than due to death), then the Deferred Payments, if any, that are payable within the first six (6) months following Executive&#x2019;s separation from service, will become payable on the first payroll date that occurs on or after the date six (6) months and one (1) day following the date of Executive&#x2019;s separation from service. All subsequent Deferred Payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit. </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notwithstanding </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">anything herein to the contrary, if Executive dies following Executive&#x2019;s separation from service, but prior to the six (6) month anniversary of the separation from service, then any payments delayed in accordance with this paragraph will be payable in a lump sum as soon as administratively practicable after the date of Executive&#x2019;s death and all other Deferred Payments will be payable in accordance with the payment schedule applicable to each payment or benefit. Each payment, installment and benefit payable under this Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Without limitation, any amount paid under this Agreement that satisfies the requirements of the </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;short-term </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">deferral&#x201d; rule set forth in Section 1.409A- 1(b)(4) of the Treasury Regulations is not intended to constitute Deferred Payments for purposes of clause (i) above.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Without limitation, any amount paid under this Agreement that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A-1(b)(9)(iii) of the Treasury Regulations that does not exceed the Section 409A Limit is not intended to constitute Deferred Payments for purposes of clause (i) above. </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Any </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">payment intended to qualify under this exemption must be made within the allowable time period specified in Section 1.409A-1(b)(9)(iii) of the Treasury Regulations.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(v)</font><div style="width:100%;display:inline;"><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">To the extent that reimbursements or in-kind benefits under this Agreement constitute non-exempt &#x201c;nonqualified deferred compensation&#x201d; for purposes of Section 409A, (1) all reimbursements hereunder shall be made on or prior to the last day of the calendar </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">year </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">following the calendar year in which the expense was incurred by </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive, </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(2) any right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit</font><font style="color:#545454;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and (3) the amount of expenses eligible for reimbursement or in-kind benefits provided in any calendar year shall not in any way affect the expenses eligible for reimbursement or in-kind benefits to be provided, in any other calendar year.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(vi)</font><div style="width:100%;display:inline;"><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Any tax gross-up that Executive is entitled </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">to </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">receive under this Agreement or otherwise shall be paid to </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">no later than December 31</font><font style="color:#2b2d2d;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;min-width:fit-content;">st</font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> of the calendar year following the calendar year in which </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">remits the related taxes.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(vii)</font><div style="width:100%;display:inline;"><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notwithstanding any other provision of this Agreement to the contrary, in no event shall any payment under this </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Agreement </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">that constitutes </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;nonqualified </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">d</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">eferred compensation</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">for purposes of Code Section 409A be subject to offset b</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">any other amount unl</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">e</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ss otherwise permitted by Code Section 409A.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(viii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The foregoing provisions are intended to be -exempt from or comply with the requirements of Section 409A so that none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and an</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ambiguities or ambiguous terms herein will be interpreted to be exempt or so comply</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Company and Executive agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under Section 409A.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.587%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Resignation from Board</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  If Executive is serving on the Company&#x2019;s Board of Directors (&#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Board</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) at the time Executive&#x2019;s employment with the Company terminates, then (i) Executive shall immediately resign from the Board and (ii) Executive&#x2019;s receipt of payment under Section 3 (except for payment required by law) shall be subject to and conditioned upon Executive resigning from the Board.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Limitation on Payments</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Anything in this </font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">A</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">greement to the contrary notwithstanding</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">if any payment or benefit Executive would receive from the Company or otherwise </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Payment</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">would (i) constitute a </font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">parachute payment</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">within the meaning of Section 280G of the Code; and (ii) but for this sentence</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">be subject to the excise tax imposed by Section 4999 of the Code (the &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Excise Tax</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">)</font><font style="color:#444446;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">then such Payment shall be equal to the Reduced Amount. The &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Reduced Amount</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#444446;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">shall be either (x) the largest portion of the Pa</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ment that would result in no portion of the Payment being </font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ubject to the Excise T</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">a</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">x</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">; </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">or (y) the largest portion, up to and including the total, of the Payment, whichever amount</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">after taking into account all applicable federal</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">state and local employment taxes</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">income taxes, and the </font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">E</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">xcise Tax (all computed at the highest applicable marginal rate)</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">results in Executive&#x2019;s receipt, on an after-tax basis, of the greater amount of the Payment. Any reduction made pursuant to this Section 5(a) shall be made in accordance with the following order of priority: (i) stock options whose exercise price exceeds the fair market </font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">v</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">alue of the optioned stock </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#444446;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">U</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">nderwater Options</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">)</font><font style="color:#444446;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(ii) Full Credit Payments (as defined below)</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">that are payable in cash</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(iii) non-cash Full Credit Payments that are taxable, (iv) non-cash Full Credit Payments that are not taxable</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(v) Partial Credit Payments (as defined below) and (vi) non-cash employee welfare benefits</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">In each case, reductions shall be made in reverse chronological order such that the payment or benefit owed on the latest date following the occurrence of the event triggering the excise tax will be the first payment or benefit to be reduced (with reductions made pro-rata in the event payments or benefits are owed at the same time)</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Full Credit Payment</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#444446;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">means a payment</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">distribution or benefit</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">whether paid or pa</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">able or distributed or distributable pursuant to the terms of this Agreement or otherwise</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">that if reduced in value b</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">one dollar reduces the amount of the parachute payment (as defined in Section 280G of the Code) by one dollar</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">determined as if such payment</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">distribution or benefit had been paid or distributed on the date of the event triggering the excise tax. &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Partial Credit Payment</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">means any payment, distribution or benefit that is not a Full Credit Payment. In no event shall the Executive have any discretion with respect to the ordering of payment reductions.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Unless the Compan</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and E</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">x</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ecutive otherwise agree in writing</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">any determination required under this Section 5 will be made in writing by an independent firm (the </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Firm</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">)</font><font style="color:#444446;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">whose determination will be conclusive and binding upon </font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">E</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">xecutive and the Company for all purposes. For purposes of making the calculations required by this Section 5, the Firm may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and Executive will furnish to the Firm such information and documents as the Firm may reasonably request in order to make a determination under this Section 5. The Company will bear all costs the Firm may reasonably incur in connection with any calculations contemplated by this Section 5.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.794%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:6.667%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Definition of Terms.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> The following terms referred to in this Agreement will have the following meanings:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Cause.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Cause</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">means:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.759%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:20.398%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.269%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s conviction of, or pleading guilty or nolo contendere to, any felony or a lesser crime involving dishonesty or moral turpitude;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.081%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:19.731%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.935%;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s willful failure to perform Executive&#x2019;s duties and responsibilities to the Company or Executive&#x2019;s violation of any written Company policy or agreement;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:19.538%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:19.204%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:3.463%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s commission of any act of fraud, embezzlement, dishonesty against the Company or any other intentional misconduct that has caused or is reasonably expected to result in injury to the Company;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:19.702%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:19.333%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:3.333%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s unauthorized use or disclosure of any proprietary information or trade secrets of the Company or any other party to whom the </font><font style="color:#494949;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">owes an obligation of nondisclosure as a result of his or her relationship with the Company;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.217%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:19.87%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.796%;text-indent:0;display:inline-flex;justify-content:flex-start;">(v)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s failure to reasonably cooperate with the Company in any investigation or formal proceeding after receiving a written request to do so; or</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:19.566%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:19.204%;text-align:left;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:3.463%;text-indent:0;display:inline-flex;justify-content:flex-start;">(vi)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s material breach of any of his or her obligations under any written agreement or covenant with the Company.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:2.13%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.7281087156432%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Change in Control.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Change in Control</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">means the occurrence of any of the following:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.759%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:20.398%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.269%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The consummation of a merger or consolidation of the Company with or into another entity or any other corporate reorganization, if the Company&#x2019;s stockholders immediately prior to such merger, consolidation or reorganization cease to directly or indirectly own immediately after such merger, consolidation or reorganization at least a majority of the combined voting power of the continuing or surviving entity&#x2019;s securities outstanding immediately after such merger, consolidation or other reorganization;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.759%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:20.398%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.269%;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The consummation of the sale, transfer or other disposition of all or substantially all of the Company&#x2019;s assets (other than (x) to a corporation or other entity of which at least a majority of its combined voting power is owned directly or indirectly by the Company, (y) to a corporation or other entity owned directly or indirectly by the stockholders of </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:20.398%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Company in substantially the same proportions as their ownership of the common stock of the Company or (z) to a continuing or surviving entity described in Section 6(b)(i) in connection with a merger, consolidation or corporate reorganization which does not result in a Change in Control under Section 6(b)(i));</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:19.592%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:19.204%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:3.463%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">A change in the effective control of the Company which occurs on the date that a majority of members of the Board is replaced during any twelve</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.009%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(12) month period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purposes of this clause, if any Person (as defined below in Section 6(b)(iv)) is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change in Control; or</font></p>
  <div class="item-list-element-wrapper" style="text-indent:19.728%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:19.333%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:3.333%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The consummation of any transaction as a result of which any Person becomes the &#x201c;beneficial owner&#x201d; (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the </font><font style="color:#545454;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#545454;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exchange </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Act</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">)), </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">directly or indirectly, of securities of the Company representing at least fifty percent (50%) of the total voting power represented by the Company&#x2019;s then outstanding voting securities. For purposes of this clause (iv), the term &#x201c;person&#x201d; shall have the same meaning as when used in sections 13(d) and 14(d) of the Exchange Act but shall exclude:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:27.211%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:26.667%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:5.067%;text-indent:0;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">a trustee or other fiduciary holding securities under an employee benefit plan of the Company or an affiliate of the Company;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:27.075%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:26.537%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:5.196%;text-indent:0;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">a corporation or other entity owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the common stock of the Company;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:26.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:26.667%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:5.067%;text-indent:0;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Company; and</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:27.039%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:26.537%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:5.196%;text-indent:0;display:inline-flex;justify-content:flex-start;">(4)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">a corporation or other entity of which at least a majority of its combined voting power is owned directly or indirectly by the Company.</font></div></div>
  <p style="margin-left:2.133%;text-indent:13.889%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.87%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">A transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Company&#x2019;s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#x2019;s securities immediately before such transactions. For the avoidance of doubt, an initial public offering of the common stock of the Company shall not constitute a Change in Control for purposes of this Agreement.</font></p>
  <div class="item-list-element-wrapper" style="text-indent:13.587%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Code</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.	&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Code</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the Internal Revenue Code of 1986, as amended</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.587%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Disability.  &#x201c;Disability&#x201d; means that because of physical or medical impairment, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive is unable, with or without reasonable accommodation, to perform the essential functions pertaining to Executive&#x2019;s position with the Company for a period exceeding 4 months.</font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="text-indent:13.643%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:13.333%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Good Reason.</font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> &#x201c;</font><font style="color:#232323;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Good Reason</font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#232323;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">means Executive&#x2019;s termination of employment within ninety (90) days following the expiration of any cure period (discussed below) following the occurrence, without Executive&#x2019;s consent, of one or more of the following:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.464%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">A material reduction of Executive&#x2019;s duties, authority or responsibilities, relative to Executive&#x2019;s duties, authority or responsibilities in effect immediately prior to such reduction; provided, however, that a reduction in duties, authority or responsibilities solely by virtue of the Company being acquired and made part of a larger entity (as, for example, when the Chief Executive Officer of the Company remains as such following a Change of Control but is not made the Chief Executive Officer of the acquiring corporation) will not constitute Good Reason;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.464%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">A material reduction in Executive&#x2019;s base compensation (except where </font><font style="color:#3a3a3a;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">there </font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">is a reduction applicable to all similarly situated executive officers generally); provided, that a reduction of less than ten percent (10%) will not be considered a material reduction in base compensation;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.464%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">A material change in the geographic location of Executive&#x2019;s primary work facility or location; provided, that a relocation of less than thirty-five (35) miles from Executive&#x2019;s then-present work location will not be considered a material change in geographic location; or</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.464%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">A material breach by the Company of a material provision of this Agreement or a failure of a successor entity in the Change of Control to assume this Agreement;</font></div></div>
  <p style="margin-left:1.867%;text-indent:13.909%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.176%;text-align:left;"><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive will not resign for Good Reason without first providing the Company with written notice within sixty (60) days of the event that Executive believes constitutes &#x201c;Good Reason&#x201d; specifically identifying the acts or omissions constituting the grounds for Good Reason and a reasonable cure period of not less than thirty (30) days following the date of such notice during which such condition must not have been cured.</font></p>
  <div class="item-list-element-wrapper" style="text-indent:13.643%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:13.333%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 409A.</font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#3a3a3a;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#3a3a3a;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section </font><font style="color:#232323;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">409A</font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#232323;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">means Code Section 409A, and the final regulations and any guidance promulgated thereunder or any state law equivalent.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.643%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:13.333%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(g)</font><div style="width:100%;display:inline;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 409A Limit.</font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> &#x201c;</font><font style="color:#232323;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 409A Limit</font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#232323;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">will mean two (2) times the lesser of: (i) Executive&#x2019;s annualized compensation based upon the annual rate of pay paid to Executive during the Executive&#x2019;s taxable year preceding the Executive&#x2019;s taxable year of his or her separation from service as determined under Treasury Regulation Section 1.409A-l(b)(9)(iii)(A)(l) and any Internal Revenue Service guidance issued with respect thereto; or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(l 7) of the Internal Revenue Code for the year in which Executive&#x2019;s separation from service occurred.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.821%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:6.667%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Successors</font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.643%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:13.333%;text-align:justify;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Company&#x2019;s Successors.</font><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company&#x2019;s business and/or assets will assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term &#x201c;Company&#x201d; will include any successor to the Company&#x2019;s business and/or assets which executes and delivers the assumption agreement described in this Section 7(a) or which becomes bound by the terms of this Agreement by operation of law.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.643%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:13.333%;text-align:justify;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s Successors.</font><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> The terms of this Agreement and all rights of Executive hereunder will inure to the benefit of, and be enforceable by, Executive&#x2019;s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">8.</font><div style="width:100%;display:inline;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Arbitration.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.624%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.13%;min-width:13.333%;text-align:justify;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Arbitration.</font><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> In consideration of Executive&#x2019;s employment with the Company, its promise to arbitrate all employment-related disputes, and Executive&#x2019;s receipt of the compensation, pay raises and other benefits paid to Executive by the Company, at present and in the future, Executive agrees that any and all controversies, claims, or disputes with anyone (including the Company and any employee, officer, director, stockholder or benefit plan of the Company in their capacity as such or otherwise) arising out of, relating to, or resulting from Executive&#x2019;s employment with the Company or termination thereof, and which are subject to arbitration, including any breach of this Agreement, will be resolved through binding arbitration under the Arbitration Rules set forth in California Code of Civil Procedure Section 1280 through 1294.2, including Section 1281.8 (the </font><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">&#x201c;</font><font style="color:#242424;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Act</font><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">&#x201d;</font><font style="color:#242424;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">), </font><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and pursuant to California law. The Federal Arbitration Act shall also apply with full force and effect, notwithstanding the application of procedural rules set forth under the Act.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.605%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.333%;text-align:justify;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Dispute Resolution.</font><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#242424;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Disputes that Executive agrees to arbitrate, and thereby agrees to waive any civil action and right to a trial by jury, include any statutory claims under local, state, or federal law </font><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(except those which are expressly excluded by statute, state law, or applicable court decision from being resolved by mandatory arbitration), including, but not limited to, claims under Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act of 1990, the Age Discrimination in Employment Act of 1967, the Older Workers Benefit Protection Act, the Sarbanes Oxley Act, the Worker Adjustment and Retraining Notification Act, the Family and Medical Leave Act, the California Family Rights Act, claims of harassment, discrimination, and wrongful termination, and any statutory or common law claims. Additionally, Executive and the Company voluntarily agree to arbitrate any claims under the California Fair Employment and Housing Act and the California Labor Code. Executive further understands that this Agreement to arbitrate also applies to any disputes that the Company may have with Executive.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Procedure.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive agrees that any arbitration will be administered by the Judicial Arbitration &amp; Mediation Services</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Inc. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">JAMS</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">)</font><font style="color:#4b4b4b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">pursuant to its Employment Arbitration Rules &amp; Procedures (the &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">JAMS Rules</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">). </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The arbitrator shall have the power to decide any motions brought by any party to the arbitration, including motions for summary judgment and/or adjudication, motions to dismiss and demurrers</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and motions for class certification, prior to any arbitration hearing. The arbitrator shall have the power to award any remedies available under applicable law, and the arbitrator shall award attorneys&#x2019; fees and costs to the prevailing party, except as prohibited by law. The Company will pay for any administrative </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">or hearing fees charged by the administrator or JAMS</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and all arbitrator&#x2019;s fees, except that Executive shall pay any filing fees associated with any arbitration that Executive initiates, but only so much of the filing fee as Executive would have instead paid had Executive filed a complaint in a court of law. Executive agrees that the arbitrator shall administer and conduct any arbitration in accordance with California law</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">including the California Code of Civil Procedure and the California Evidence Code</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and that the arbitrator shall apply substantive and procedural California law to any dispute or claim</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">without reference to the rules of conflict of law. To the extent that the JAMS Rules conflict with California law, California law shall take precedence</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The decision of the arbitrator shall be in writing. Any arbitration under this Agreement shall be conducted in Sacramento County</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">California</font><font style="color:#5e5e5e;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Remedy.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Except as provided by the Act, arbitration shall be the sole</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">exclusive, and final remedy for any dispute between Executive and the Company. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Accordingly, except as provided by the Act and this Agreement, neither Executive nor the Company will be permitted to pursue court action regarding claims that are subject to arbitration. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notwithstanding, the arbitrator will not have the authority to disregard or refuse to enforce any lawful Company policy, and the arbitrator will not order or require the Company to adopt a policy not otherwise required by law that the Company has not adopted.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Administrative Relief.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive is not prohibited from pursuing an administrative claim with a local, state</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">or federal administrative body or government agency that is authorized to enforce or administer laws related to employment, including, but not limited to</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Department of Fair Employment and Housing</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Equal Employment Opportunity Commission</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the National Labor Relations Board, or the Workers&#x2019; Compensation Board. However, Executive may not pursue court action regarding any such claim</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">except as permitted by law.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Voluntary Nature of Agreement.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive acknowledges and agrees that Executive is executing this Agreement voluntarily and without any duress or undue influence by the Company or anyone else</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive further acknowledges and agrees that Executive has carefully read this Agreement and that Executive has asked any questions needed for Executive to understand the terms</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">consequences and binding effect of this Agreement and fully understands it</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">including that </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">EXECUTIVE IS WAIVING EXECUTIVE&#x2019;S RIGHT TO A JURY TRIAL. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Finally, Executive agrees that Executive has been provided an opportunity to seek the advice of an attorney of Executive&#x2019;s choice before signing this Agreement.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.784%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:6.667%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">9.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Confidential Information.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive agrees to comply with and be bound by the Employee Confidentiality and Intellectual Property Rights Agreement (the &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Confidential Information Agreement</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">entered into by and between Executive and the Company, dated August 20, 2024. Notwithstanding the foregoing, Executive is not prevented from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct Executive has reason to believe is unlawful. </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">10.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notice</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.733%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:13.731%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.402%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">General</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Notices and all other communications contemplated by this Agreement will be in writing and will be deemed to have been duly given when personally delivered or when mailed by U.S. registered or certified mail, return receipt requested and postage </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:13.731%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">prepaid. In the case of Executive, mailed notices will be addressed to him or her at the home address which he or she most recently communicated to the Company in writing. In the case of the Company, mailed notices will be addressed to its corporate headquarters, and all notices will be directed to the attention of its General Counsel.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.733%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:13.731%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.402%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notice of Termination</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Any termination by the Company for Cause or by Executive for Good Reason will be communicated by a notice of termination to the other party hereto given in accordance with Section 10(a) of this Agreement. Such notice will indicate the specific termination provision in this Agreement relied upon, will set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination under the provision so indicated, and will specify the termination date (which will be not more than thirty (30) days after the giving of such notice). The failure by Executive to include in the notice any fact or circumstance which contributes to a showing of Good Reason will not waive any right of Executive hereunder or preclude Executive from asserting such fact or circumstance in enforcing his or her rights hereunder.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:11pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">11.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Miscellaneous Provisions.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.605%;font-size:0;margin-top:11.65pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">No Duty to Mitigate.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#4f4f4f;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">will not be required to mitigate the amount of any payment contemplated by this Agreement, nor will any such payment be reduced by any earnings that Executive may receive from any other source.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.605%;font-size:0;margin-top:11.3pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Waiver.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> No provision of this Agreement will be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party will be considered a waiver of any other condition or provision or of the same condition or provision at another time.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12.15pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Headings.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12.15pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Entire Agreement.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> This Agreement constitutes the entire agreement of the parties hereto and supersedes in their entirety all prior or contemporaneous</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">representations, understandings</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">undertakings or agreements (whether oral or written and whether expressed or implied) of the parties with respect to the subject matter hereof, including, without limitation, any severance provisions contained in the </font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">E</font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">mployment Agreement. Executive acknowledges and agrees that this Agreement encompasses all the rights of Executive to any severance payments and/or benefits based on the termination of Executive&#x2019;s employment and Executive hereby agrees that he or she has no such rights except as stated herein. No waiver</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">alteration</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">or modification of any of the provisions of this Agreement will be binding unless in writing and signed by duly authorized representatives of the parties hereto and which specifically mention this Agreement.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.469%;font-size:0;margin-top:11.1pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.204%;text-align:justify;"><font style="color:#2b2b2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.93%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#2b2b2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Choice of Law.</font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> The validity, interpretation</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">construction and performance of this Agreement will be governed by the laws of the State of California (with the exception o</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">f </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">its conflict of laws provisions).</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.605%;font-size:0;margin-top:12.05pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.333%;text-align:justify;"><font style="color:#2b2b2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#2b2b2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Severability.</font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> The invalidity or unenforceability of any provision or </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12.05pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">provisions of this Agreement will not affect the validity or enforceability of any other provision hereof, which will remain in full fo</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">r</font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ce and effect.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.605%;font-size:0;margin-top:11.65pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.333%;text-align:justify;"><font style="color:#2b2b2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(g)</font><div style="width:100%;display:inline;"><font style="color:#2b2b2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Withholding</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">All payments made pursuant to this Agreement will be subject to withholding of applicable income</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">employment and other taxes</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">as determined in the Company</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s reasonable judgment.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.605%;font-size:0;margin-top:12.7pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.333%;text-align:justify;"><font style="color:#2b2b2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(h)</font><div style="width:100%;display:inline;"><font style="color:#2b2b2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Counterparts</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">This Agreement may be executed in counterparts, each of which will be deemed an original</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">bu</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">t </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">all of which together will constitute one and the same instrument.</font></div></div>
  <p style="margin-left:1.773%;font-size:10pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.63%;text-align:center;"><font style="color:#2b2b2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">[Signature Page Follows]</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:0.7in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:2.013%;text-indent:6.997%;font-size:10pt;margin-top:3.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.898%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">IN WITNESS WHEREOF</font><font style="color:#464954;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">each of the parties has executed this Agreement, in the case of the Company by its duly authorized officer</font><font style="color:#464954;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">on the day and year set forth below.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:10.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:2.08%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">COMPANY	ARCADIA BIOSCIENCES, INC.</font></p>
  <p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:41.96%;text-indent:-0.054%;padding-left:0.027%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">By</font><font style="color:#464954;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">:  </font><font style="color:#464954;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">/s/ KEVIN COMCOWICH	</font></p>
  <p style="margin-left:41.96%;text-indent:-0.054%;padding-left:0.027%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:41.96%;text-indent:-0.054%;padding-left:0.027%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Name:  </font><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Kevin Comcowich	</font></p>
  <p style="font-size:10pt;margin-top:0.6pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:41.987%;text-indent:-0.054%;padding-left:0.027%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Title:  </font><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Chairman of the Board	</font></p>
  <p style="margin-left:41.987%;text-indent:-0.054%;padding-left:0.027%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Date:  </font><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">August 22, 2024	</font></p>
  <p style="margin-left:42.013%;font-size:10pt;margin-top:3.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:2.08%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">EXECUTIVE	THOMAS J.  SCHAEFER</font></p>
  <p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:41.96%;text-indent:-0.054%;padding-left:0.027%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">By</font><font style="color:#464954;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">:  </font><font style="color:#464954;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">/s/ THOMAS J. SCHAEFER</font></p>
  <p style="margin-left:41.96%;text-indent:-0.054%;padding-left:0.027%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:41.96%;text-indent:-0.054%;padding-left:0.027%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Name:  </font><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Thomas J. Schaefer	</font></p>
  <p style="font-size:10pt;margin-top:0.6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:41.987%;text-indent:-0.048%;padding-left:0.027%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.898%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Title:  </font><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Chief Executive Officer	</font></p>
  <p style="margin-left:41.987%;text-indent:-0.048%;padding-left:0.027%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.898%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Date:  </font><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">August 20, 2024	</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.7in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  </font><font><font style="white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">www.arcadiabio.com</font></font></p></div></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>rkda-ex10_2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html>
 <head>
  <title>EX-10.2</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="min-height:0.9in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img6294127_0.jpg" alt="img6294127_0.jpg" style="width:194px;height:138px;">&#160;</p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">August 20, 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Mark Kawakami</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">[Address]</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Dear Mark:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">This letter sets forth the terms of your employment as Chief Financial Officer of Arcadia Biosciences, Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), a position you have held since July 5, 2024 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Effective Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). The terms set forth below shall be effective as of the Effective Date.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Title and Base Salary</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  You will report directly to Thomas Schaefer, Chief Executive Officer.  Beginning on the Effective Date, your annual base salary shall be $212,063.  The salary shall be subject to an annual review and may be increased at the discretion of the Company&#x2019;s Board of Directors.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Bonus Compensation</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  In addition to your base salary, you will be eligible for an annual incentive cash bonus, as determined by the Company. For calendar year 2024, your annual incentive cash bonus shall have a target equal to 30% of your base salary as of the Effective Date, prorated for the portion of 2024 during which you are employed by the Company as the Company&#x2019;s Chief Financial Officer, and 20% of your base salary immediately before your appointment as the Company&#x2019;s Chief Financial Officer, prorated for the portion of 2024 during which you were employed as the Company&#x2019;s vice president of finance.  The target bonus and its components, the Company performance goals, and your individual objectives shall be determined and documented each year by the Compensation Committee of the Board of Directors (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Compensation Committee</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Equity Awards</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:11.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.111%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Company may grant equity awards to you from time to time, which will be subject to the terms of the applicable equity compensation plan or arrangement in effect at the time of grant. The Compensation Committee will determine in its discretion whether you will be granted any such equity awards and the terms and conditions of any such awards in accordance with the terms of any applicable equity plan. You should be aware that you may incur federal and state income taxes as a result of your receipt, or the vesting of any equity compensation awards and it shall be your responsibility to pay any such applicable taxes.</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Severance and Change in Control Agreement</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  You will have the benefits set forth in a Severance and Change in Control Agreement between you and the Company to be executed on the date of this letter and to be effective as of the Effective Date, a copy of which is attached hereto (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Severance Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.657%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Other Benefits</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">You will be eligible for all Company adopted benefits, under the terms and conditions of such benefit plans.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Your employment is &#x201c;at-will,&#x201d; which means that either you or the Company may terminate the employment relationship at any time for any reason or for no reason (subject to the terms of the Severance Agreement). This at-will relationship may not be modified by any oral or implied agreement.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Confidentiality Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  As a condition to you continuing employment with the Company, you will execute on the date of this letter the Company&#x2019;s Confidentiality and Invention Assignment Agreement, a copy of which is attached hereto (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Confidentiality Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">This letter, the Severance Agreement, the Confidentiality Agreement, and any policies that the Company may adopt from time to time constitute the entire agreement relating to the terms of your employment with the Company.  Please sign, date and return this letter to the Company to acknowledge the terms hereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">If you should have any questions, please feel free to call me.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Sincerely,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">/s/ THOMAS SCHAEFER</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Thomas Schaefer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Chief Executive Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ACCEPTED BY:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">/s/ MARK KAWAKAMI</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Mark Kawakami</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">August 20, 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">August 20, 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img6294127_1.jpg" alt="img6294127_1.jpg" style="width:195px;height:138px;">&#160;</p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.38%;text-align:center;"><font style="color:#2b2b2b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">SEVERANCE </font><font style="color:#3b3b3b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">AND </font><font style="color:#2b2b2b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">CHANGE IN CONTROL AGREEMENT</font></p>
  <p style="text-indent:6.769%;font-size:10pt;margin-top:12.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.315%;text-align:justify;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">This Severance and Change in Control Agreement (the </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#3b3b3b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Agreement</font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#3b3b3b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">is made and entered into by and between Mark Kawakami (&#x201c;</font><font style="color:#2b2b2b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive</font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and Arcadia Biosciences, Inc. (the &#x201c;</font><font style="color:#2b2b2b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Company</font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), effective as of July 5, 2024 (the </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#3b3b3b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Effective </font><font style="color:#2b2b2b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Date</font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></p>
  <p style="margin-left:1.773%;font-size:10pt;margin-top:11.75pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.38%;text-align:center;"><font style="color:#2b2b2b;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">RECITALS</font></p>
  <div class="item-list-element-wrapper" style="text-indent:6.748%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.204%;min-width:6.667%;text-align:justify;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Compensation Committee of the Board of Directors of the Company (the </font><font style="color:#4f4f4f;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#4f4f4f;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Committee</font><font style="color:#4f4f4f;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#4f4f4f;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">recognizes that it is possible that the Company could terminate Executive&#x2019;s at-will employment with the Company and from time to time the Company may consider the possibility of an acquisition by another company or other change in control transaction. The Committee also recognizes that such considerations can be a distraction to Executive and can cause Executive to consider alternative employment opportunities. The Committee has determined that it is in the best interests of the Company and its stockholders to assure that the Company </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">will </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">have the continued dedication and objectivity of Executive, notwithstanding the possibility, threat or occurrence of such a termination of employment or the occurrence of a Change in </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Control </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(as defined herein) of the Company.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.748%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.204%;min-width:6.667%;text-align:justify;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Committee believes that it is in the best interests of the Company and its stockholders to provide </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive with </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">an incentive to continue his employment </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">with </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Company and to motivate Executive to maximize </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the value </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">of the Company for </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">benefit of its stockholders.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.748%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.204%;min-width:6.667%;text-align:justify;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Committee believes that it is imperative to provide Executive with certain severance benefits upon </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">termination of employment and with certain additional benefits following a Change in </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Control. These </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">benefits </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">will </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">provide </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">with enhanced financial security and incentive and encouragement to remain with the </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Company </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">notwithstanding the possibility of </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">a </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Change in Control.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.748%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.204%;min-width:6.667%;text-align:justify;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Company </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">have entered into </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">an </font><font style="color:#2b2b2b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">employment terms letter dated August 20, 2024 and made effective as of July 5, 2024 (the </font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#3b3b3b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Employment Letter</font><font style="color:#3b3b3b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#3b3b3b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">).</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.738%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Company and Executive wish to state the terms of Executive&#x2019;s severance and benefits (whether or not in connection with a Change in Control) and state any and all such provisions providing for severance and/or change in control payments, as set forth below. All other terms and conditions of the Employment Letter will remain in full force and effect.</font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Certain capitalized terms used in the Agreement are defined in Section 6</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">below.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">AGREEMENT</font></p>
  <p style="text-indent:6.68%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows:</font></p>
  <div class="item-list-element-wrapper" style="text-indent:6.738%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Term of Agreement</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Agreement shall terminate on the third (3</font><font style="color:#2d2d2d;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;min-width:fit-content;">rd</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) anniversary of the Effective Date (the &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Term End Date</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">); </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">provided, however, that if as of the Term End Date Executive is receiving benefits under Section 3 of this Agreement, then the Agreement shall continue in effect until such date as all of the obligations of the parties hereto with respect to this Agreement have been satisfied.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.738%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">At-Will Employment</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Company and Executive acknowledge that, notwithstanding this Agreement and any benefits provided for herein, Executive&#x2019;s employment is and will continue to be at-will, as defined under applicable law. If Executive&#x2019;s employment terminates for any reason, including (without limitation) any termination of employment not set forth in Section 3, Executive will not be entitled to any payments, benefits, damages, awards or compensation other than the payment of accrued but unpaid wages and vacation, if any, as required by law, and any unreimbursed reimbursable expenses or pursuant to written agreements with the Company, including equity award agreements.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Severance Benefits.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.477%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination without Cause and not in Connection with a Change in Control.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> If the Company terminates Executive&#x2019;s employment with the Company for a reason other than Cause, Executive becoming Disabled, or Executive&#x2019;s death, at any time other than during the twelve (12)-month period immediately following a Change in Control, then, subject to Section 4, Executive will receive the following severance benefits from the Company:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;text-indent:20.787%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20.398%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:1.4838111366477158%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Accrued Compensation.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> The Company will pay Executive all accrued but unpaid vacation, expense reimbursements, wages, and other benefits due to Executive under any Company-provided plans, policies, and arrangements.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;text-indent:20.243%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:19.87%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.0160477400104835%;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Severance Payment.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive will receive continuing payments of severance for a period of six (6) months (such number of months, the &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Standard Severance Period</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">from the date of such termination of employment at a rate equal to Executive&#x2019;s base salary as in effect immediately prior to the date of Executive&#x2019;s termination of employment (disregarding any reduction in base salary that triggers the right to termination for Good Reason), less all required tax withholdings and other applicable deductions</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">which will be paid in accordance with the Company</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s regular payroll procedures.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;text-indent:19.672%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.602%;min-width:19.204%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.6883996613039796%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Continued Employee Benefits.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> If Executive elects continuation coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">as amended </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">COBRA</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">for Executive and Executive</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s eligible dependents</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">within the time period prescribed pursuant to COBRA, the Company will reimburse Executive for the COBRA premiums for such coverage (at the coverage levels in effect immediately prior to Executive&#x2019;s </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.602%;min-width:19.204%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">termination or resignation) until the earlier of (A) the end of the Standard Severance Period, or (B) the date upon which Executive and</font><font style="color:#5d5d5d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">/</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">or Executive</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s eligible dependents becomes covered under similar plans. COBRA reimbursements will be made by the Company to Executive consistent with the Company&#x2019;s normal expense reimbursement policy and will be </font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">t</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">axable to the extent required to avoid adverse consequences to Executive or the Company under either Code Section 105(h) or the Patient Protection and Affordable Care Act of 2010.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pro-Rated Bonus.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Following the end of the year in which Executive&#x2019;s employment with the Company terminates</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">but no later than March 15 of such following year</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Committee, and if applicable</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Company</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s Board of Directors </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Board</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">), </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">shall determine in good faith the annual cash bonus that Executive would have been entitled to receive for the year of termination if Executive had remained employed by the Company through the end of such year (such hypothetical bonus, the </font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination Year Bonus</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">). </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Company will pay Executive a pro-rated portion of the Termination Year Bonus based on the percentage of the year that Executive was employed by the Company in the year of termination. This amount will be payable on or before the earlier of (i) March 15 of the year immediately following the year of Executive&#x2019;s termination and (ii) the date that the Company pays annual cash bonuses to other executives of the Company with respect to the year of </font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">E</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">xecutive</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s termination</font><font style="color:#111111;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;text-indent:20.411%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:19.87%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.0160477400104835%;text-indent:0;display:inline-flex;justify-content:flex-start;">(v)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Payments or Benefits Required by Law.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive will receive such other compensation or benefits from the Company as may be required by law.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.587%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination without Cause or Resignation for Good Reason in Connection with a Change in Control.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> If during the twelve (12)-month period immediately following a Change in Control, (x) the Company terminates Executive&#x2019;s employment with the Company for a reason other than Cause</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive becoming Disabled, or Executive&#x2019;s death</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">or (y) Executive resigns from such employment for Good Reason, then</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">subject to Section 4</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive will receive the following severance benefits from the Company in lieu of the benefits described in Section 3(a) above:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Accrued Compensation.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> The Company will pay Executive all accrued but unpaid vacation, expense reimbursements</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">wages</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and other benefits due to Executive under any Company-provided plans, policies, and arrangements.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Severance Payment.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive will receive continuing pa</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ments of severance for a period of twelve (12) months (such number of months</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Enhanced Severance Period</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">from the date of such termination of employment at a rate equal to Executive&#x2019;s base salary as in effect immediately prior to the date of Executive&#x2019;s termination of employment (disregarding any reduction in base salary that triggers the right to termination for Good Reason), less all required tax withholdings and other applicable deductions, which will be paid in accordance with the Company&#x2019;s regular payroll procedures.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Continued Employee Benefits.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> If Executive elects continuation coverage pursuant to COBRA for Executive and Executive</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s eligible dependents</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">within the time period prescribed pursuant to COBRA</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Company will reimburse Executive for the COBRA premiums for such coverage (at the coverage levels in effect immediately prior to Executive&#x2019;s termination or resignation) until the earlier of (A) the end of the Enhanced Severance Period</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">or (B) the date upon which Executive and/or Executive&#x2019;s eligible dependents becomes covered under similar plans. COBRA reimbursements will be made by the Company </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">to Executive consistent with the Company&#x2019;s normal expense reimbursement policy and will be taxable to the extent required to avoid adverse consequences to Executive or the Company under either Code Section 105(h) or the Patient Protection and Affordable Care Act of 2010.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Equity.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive will be entitled to accelerated vesting as to one hundred percent (100%) of the then-unvested portion of all of </font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">E</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">xecutive&#x2019;s outstanding equity awards.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(v)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pro-Rated Bonus.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Following the end of the year in which Executive&#x2019;s employment with the Company terminates</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">but no later than March 15 of such following year, the Committee</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and if applicable, the Board</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">shall determine in good faith the Termination Year Bonus (as defined above). The Compan</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">will pa</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive a pro&shy; rated portion of the Termination Year Bonus based on the percentage of the year that Executive was employed by the Company in the year of termination. This amount will be payable on or before the earlier of (i) March 15 of the year immediately following the year of Executive&#x2019;s termination and (ii) the date that the Company pays annual cash bonuses to other executives of the Company with respect to the year of Executive</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s termination.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(vi)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Payments or Benefits Required by Law</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive will receive such other compensation or benefits from the Company as may be required by law.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.587%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Disability; Death</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">If Executive</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s employment with the Company is terminated due to Executive becoming Disabled or Executive</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s death</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">then </font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">E</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">xecutive or Executive&#x2019;s estate (as the case may be) will (i) receive the earned but unpaid base salary through the date of termination of employment</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(ii) receive all accrued vacation, expense reimbursements and any other benefits due to Executive through the date of termination of employment in accordance with Company-provided or paid plans, policies and arrangements, and (iii) not be entitled to any other compensation or benefits from the Company except to the extent required by law (for example</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">COBRA)</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.587%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Voluntary Resignation</font><font style="color:#484849;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">; </font><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination for Cause.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> If Executive voluntarily terminates Executive</font><font style="color:#484849;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s employment with the Company (other than for Good Reason following a Change in Control) or if the Company terminates Executive&#x2019;s employment with the Company for Cause, then Executive will (i) receive his or her earned but unpaid base salary through the date of termination of employment, (ii) receive all accrued vacation, expense reimbursements and any other benefits due to Executive through the date of termination of employment in accordance with established Company-provided or paid plans, policies and arrangements, and (iii) not be entitled to any other compensation or benefits (including, without limitation, accelerated vesting of any equity awards) from the Company except to the extent provided under agreement(s) relating to any equity awards or as may be required by law (for example, COBRA).</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.587%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Timing of Payments.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Subject to Section 4, payment of the severance and benefits hereunder shall be made or commence to be made as soon as practicable following Executive&#x2019;s termination of employment.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.587%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:13.333%;text-align:justify;"><font style="color:#464646;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#464646;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exclusive </font><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Remedy.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> In the event of a termination of Executive&#x2019;s employment with the Company pursuant to Section 3(a) or Section 3(b), the provisions of this Section 3 are intended to be and are exclusive and in lieu of any other rights or remedies to which Executive or the Company may otherwise be entitled, whether at law, tort or contract, in equity, </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">or under this Agreement (other than the payment of accrued but unpaid wages, as required by law, and any unreimbursed reimbursable expenses). Executive will be entitled to no other severance, benefits, compensation or other payments or rights upon a termination of employment, including, without limitation, any severance payments and/or benefits provided in the Employment Agreement, other than those benefits expressly set forth in Section 3 of this Agreement or pursuant to written equity award agreements with the Company.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Conditions to Receipt of Severance.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Release of Claims Agreement.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> In the event of a termination of </font><font style="color:#464646;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">employment with the Company pursuant to Section 3(a) or Section 3(b), the receipt of any severance payments or benefits pursuant to this Agreement is subject to </font><font style="color:#464646;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">signing and not revoking a separation agreement and release of claims in a form acceptable to the Company (the &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Release</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">), </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">which must become effective no later than the sixtieth (60</font><font style="color:#2d2d2d;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) day following Executive&#x2019;s termination of employment (the </font><font style="color:#464646;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#464646;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Release </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Deadline</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">), </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and if not, Executive will forfeit any right to severance payments or benefits under this Agreement. </font><font style="color:#464646;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">To </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">become effective</font><font style="color:#5d5d5d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Release must be executed by Executive and any revocation periods (as required by statute, regulation, or otherwise) must have expired without Executive having revoked the Release. In addition, in no event will severance payments or benefits be paid or provided until the Release actually becomes effective. If the termination of employment occurs at a time during the calendar year where the Release Deadline could occur in the calendar year following the calendar year in which Executive&#x2019;s termination of employment occurs, then any severance payments or benefits under this Agreement that would be considered Deferred Payments (as defined in Section 4(d)(i)) will be paid on the first payroll date to occur during the calendar year following the calendar year in which such termination occurs, or such later time as required by (i) the payment schedule applicable to each payment or benefit as set forth in Section 3, (ii) the date the Release becomes effective, or (iii) Section 4(d)(ii); provided that the first payment </font><font style="color:#232324;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">shall include all amounts that would have been paid to Executive if payment had commenced on the date of Executive&#x2019;s termination of employment.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.605%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.333%;text-align:justify;"><font style="color:#232324;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#232324;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Confidential Information Agreement and Other Requirements.</font><font style="color:#232324;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive&#x2019;s receipt of any payments or benefits under Section 3 (except for those required by law) will be subject to Executive continuing to comply with the terms of the Confidential Information Agreement (as defined in Section 9) executed by Executive in favor of the Company and the provisions of this Agreement.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#232324;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#232324;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 409A.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notwithstanding anything to the contrary in this Agreement, no severance pay or benefits to be paid or provided to Executive, if any, pursuant to this Agreement that, when considered together with any other severance payments or separation benefits, are considered deferred compensation not exempt under Section 409A (together, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Deferred Payments</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">will be paid or otherwise provided until Executive has a &#x201c;separation from service&#x201d; within the meaning of Section 409A. And for purposes of this Agreement, any reference to &#x201c;termination of employment,&#x201d; &#x201c;termination&#x201d; or any similar term shall be construed to mean a &#x201c;separation from service&#x201d; within the meaning of Section 409A. Similarly</font><font style="color:#444444;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">no severance payable to Executive, if any, pursuant to this Agreement that otherwise would be exempt from Section 409A pursuant to Treasury Regulation Section 1.409A-1(b)(9) will be payable until Executive has a &#x201c;separation from service&#x201d; within the meaning of Section 409A.</font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="text-indent:20.352%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notwithstanding anything to the contrary in this Agreement, if Executive is a </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;specified </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">employee&#x201d; within the meaning of Section 409A at the time of Executive&#x2019;s termination of employment (other than due to death), then the Deferred Payments, if any, that are payable within the first six (6) months following Executive&#x2019;s separation from service, will become payable on the first payroll date that occurs on or after the date six (6) months and one (1) day following the date of Executive&#x2019;s separation from service. All subsequent Deferred Payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit. </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notwithstanding </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">anything herein to the contrary, if Executive dies following Executive&#x2019;s separation from service, but prior to the six (6) month anniversary of the separation from service, then any payments delayed in accordance with this paragraph will be payable in a lump sum as soon as administratively practicable after the date of Executive&#x2019;s death and all other Deferred Payments will be payable in accordance with the payment schedule applicable to each payment or benefit. Each payment, installment and benefit payable under this Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Without limitation, any amount paid under this Agreement that satisfies the requirements of the </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;short-term </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">deferral&#x201d; rule set forth in Section 1.409A- 1(b)(4) of the Treasury Regulations is not intended to constitute Deferred Payments for purposes of clause (i) above.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Without limitation, any amount paid under this Agreement that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A-1(b)(9)(iii) of the Treasury Regulations that does not exceed the Section 409A Limit is not intended to constitute Deferred Payments for purposes of clause (i) above. </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Any </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">payment intended to qualify under this exemption must be made within the allowable time period specified in Section 1.409A-1(b)(9)(iii) of the Treasury Regulations.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(v)</font><div style="width:100%;display:inline;"><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">To the extent that reimbursements or in-kind benefits under this Agreement constitute non-exempt &#x201c;nonqualified deferred compensation&#x201d; for purposes of Section 409A, (1) all reimbursements hereunder shall be made on or prior to the last day of the calendar </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">year </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">following the calendar year in which the expense was incurred by </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive, </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(2) any right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit</font><font style="color:#545454;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and (3) the amount of expenses eligible for reimbursement or in-kind benefits provided in any calendar year shall not in any way affect the expenses eligible for reimbursement or in-kind benefits to be provided, in any other calendar year.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(vi)</font><div style="width:100%;display:inline;"><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Any tax gross-up that Executive is entitled </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">to </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">receive under this Agreement or otherwise shall be paid to </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">no later than December 31</font><font style="color:#2b2d2d;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;min-width:fit-content;">st</font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> of the calendar year following the calendar year in which </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">remits the related taxes.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(vii)</font><div style="width:100%;display:inline;"><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notwithstanding any other provision of this Agreement to the contrary, in no event shall any payment under this </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Agreement </font><font style="color:#2b2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">that constitutes </font><font style="color:#424242;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;nonqualified </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">d</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">eferred compensation</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">for purposes of Code Section 409A be subject to offset b</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">any other amount unl</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">e</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ss otherwise permitted by Code Section 409A.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.381%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(viii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The foregoing provisions are intended to be -exempt from or comply with the requirements of Section 409A so that none of the severance payments and </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:20%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and an</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ambiguities or ambiguous terms herein will be interpreted to be exempt or so comply</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Company and Executive agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under Section 409A.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Limitation on Payments</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Anything in this </font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">A</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">greement to the contrary notwithstanding</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">if any payment or benefit Executive would receive from the Company or otherwise </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Payment</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">would (i) constitute a </font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">parachute payment</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">within the meaning of Section 280G of the Code; and (ii) but for this sentence</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">be subject to the excise tax imposed by Section 4999 of the Code (the &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Excise Tax</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">)</font><font style="color:#444446;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">then such Payment shall be equal to the Reduced Amount. The &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Reduced Amount</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#444446;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">shall be either (x) the largest portion of the Pa</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ment that would result in no portion of the Payment being </font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ubject to the Excise T</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">a</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">x</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">; </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">or (y) the largest portion, up to and including the total, of the Payment, whichever amount</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">after taking into account all applicable federal</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">state and local employment taxes</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">income taxes, and the </font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">E</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">xcise Tax (all computed at the highest applicable marginal rate)</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">results in Executive&#x2019;s receipt, on an after-tax basis, of the greater amount of the Payment. Any reduction made pursuant to this Section 5(a) shall be made in accordance with the following order of priority: (i) stock options whose exercise price exceeds the fair market </font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">v</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">alue of the optioned stock </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#444446;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">U</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">nderwater Options</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">)</font><font style="color:#444446;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(ii) Full Credit Payments (as defined below)</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">that are payable in cash</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(iii) non-cash Full Credit Payments that are taxable, (iv) non-cash Full Credit Payments that are not taxable</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(v) Partial Credit Payments (as defined below) and (vi) non-cash employee welfare benefits</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">In each case, reductions shall be made in reverse chronological order such that the payment or benefit owed on the latest date following the occurrence of the event triggering the excise tax will be the first payment or benefit to be reduced (with reductions made pro-rata in the event payments or benefits are owed at the same time)</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Full Credit Payment</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#444446;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">means a payment</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">distribution or benefit</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">whether paid or pa</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">able or distributed or distributable pursuant to the terms of this Agreement or otherwise</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">that if reduced in value b</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">one dollar reduces the amount of the parachute payment (as defined in Section 280G of the Code) by one dollar</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">determined as if such payment</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">distribution or benefit had been paid or distributed on the date of the event triggering the excise tax. &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Partial Credit Payment</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">means any payment, distribution or benefit that is not a Full Credit Payment. In no event shall the Executive have any discretion with respect to the ordering of payment reductions.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Unless the Compan</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">y </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and E</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">x</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ecutive otherwise agree in writing</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">any determination required under this Section 5 will be made in writing by an independent firm (the &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Firm</font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">)</font><font style="color:#444446;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">whose determination will be conclusive and binding upon </font><font style="color:#444446;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">E</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">xecutive and the Company for all purposes. For purposes of making the calculations required by this Section 5, the Firm may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and Executive will furnish to the Firm such information and documents as the Firm may reasonably request in order to make a determination under this Section 5. The Company will bear all costs the Firm may reasonably incur in connection with any calculations contemplated by this Section 5.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.794%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:6.667%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Definition of Terms.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> The following terms referred to in this Agreement will have the following meanings:</font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Cause.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Cause</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">means:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.759%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:20.398%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.269%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s conviction of, or pleading guilty or nolo contendere to, any felony or a lesser crime involving dishonesty or moral turpitude;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.081%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:19.731%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.935%;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s willful failure to perform Executive&#x2019;s duties and responsibilities to the Company or Executive&#x2019;s violation of any written Company policy or agreement;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:19.538%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:19.204%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:3.463%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s commission of any act of fraud, embezzlement, dishonesty against the Company or any other intentional misconduct that has caused or is reasonably expected to result in injury to the Company;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:19.702%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:19.333%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:3.333%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s unauthorized use or disclosure of any proprietary information or trade secrets of the Company or any other party to whom the </font><font style="color:#494949;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">owes an obligation of nondisclosure as a result of his or her relationship with the Company;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.217%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:19.87%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.796%;text-indent:0;display:inline-flex;justify-content:flex-start;">(v)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s failure to reasonably cooperate with the Company in any investigation or formal proceeding after receiving a written request to do so; or</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:19.566%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:19.204%;text-align:left;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:3.463%;text-indent:0;display:inline-flex;justify-content:flex-start;">(vi)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s material breach of any of his or her obligations under any written agreement or covenant with the Company.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:2.13%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.7281087156432%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Change in Control.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Change in Control</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">means the occurrence of any of the following:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.759%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:20.398%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.269%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The consummation of a merger or consolidation of the Company with or into another entity or any other corporate reorganization, if the Company&#x2019;s stockholders immediately prior to such merger, consolidation or reorganization cease to directly or indirectly own immediately after such merger, consolidation or reorganization at least a majority of the combined voting power of the continuing or surviving entity&#x2019;s securities outstanding immediately after such merger, consolidation or other reorganization;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.759%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:20.398%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.269%;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The consummation of the sale, transfer or other disposition of all or substantially all of the Company&#x2019;s assets (other than (x) to a corporation or other entity of which at least a majority of its combined voting power is owned directly or indirectly by the Company, (y) to a corporation or other entity owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the common stock of the Company or (z) to a continuing or surviving entity described in Section 6(b)(i) in connection with a merger, consolidation or corporate reorganization which does not result in a Change in Control under Section 6(b)(i));</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:19.592%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:19.204%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:3.463%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">A change in the effective control of the Company which occurs on the date that a majority of members of the Board is replaced during any twelve</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.009%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(12) month period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purposes of this clause, if any Person (as defined below in Section 6(b)(iv)) is considered to be in effective</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.009%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change in Control; or</font></p>
  <div class="item-list-element-wrapper" style="text-indent:19.728%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:19.333%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:3.333%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The consummation of any transaction as a result of which any Person becomes the &#x201c;beneficial owner&#x201d; (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the </font><font style="color:#545454;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#545454;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exchange </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Act</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">)), </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">directly or indirectly, of securities of the Company representing at least fifty percent (50%) of the total voting power represented by the Company&#x2019;s then outstanding voting securities. For purposes of this clause (iv), the term &#x201c;person&#x201d; shall have the same meaning as when used in sections 13(d) and 14(d) of the Exchange Act but shall exclude:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:27.211%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:26.667%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:5.067%;text-indent:0;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">a trustee or other fiduciary holding securities under an employee benefit plan of the Company or an affiliate of the Company;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:27.075%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:26.537%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:5.196%;text-indent:0;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">a corporation or other entity owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the common stock of the Company;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:26.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:26.667%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:5.067%;text-indent:0;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Company; and</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:27.039%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:26.537%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:5.196%;text-indent:0;display:inline-flex;justify-content:flex-start;">(4)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">a corporation or other entity of which at least a majority of its combined voting power is owned directly or indirectly by the Company.</font></div></div>
  <p style="margin-left:2.133%;text-indent:13.889%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.87%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">A transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Company&#x2019;s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#x2019;s securities immediately before such transactions. For the avoidance of doubt, an initial public offering of the common stock of the Company shall not constitute a Change in Control for purposes of this Agreement.</font></p>
  <div class="item-list-element-wrapper" style="text-indent:13.587%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Code</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.	&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Code</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the Internal Revenue Code of 1986, as amended</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.587%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.87%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Disability.  &#x201c;Disability&#x201d; means that because of physical or medical impairment, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive is unable, with or without reasonable accommodation, to perform the essential functions pertaining to Executive&#x2019;s position with the Company for a period exceeding 4 months.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.643%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:13.333%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Good Reason.</font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> &#x201c;</font><font style="color:#232323;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Good Reason</font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#232323;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">means Executive&#x2019;s termination of employment within ninety (90) days following the expiration of any cure period (discussed below) following the occurrence, without Executive&#x2019;s consent, of one or more of the following:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.464%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">A material reduction of Executive&#x2019;s duties, authority or responsibilities, relative to Executive&#x2019;s duties, authority or responsibilities in effect immediately prior to such reduction; provided, however, that a reduction in duties, authority or responsibilities solely by virtue of the Company being acquired and made part of a larger entity (as, for example, when the Chief Financial Officer of the Company remains as such following a Change of Control but is not made the Chief Financial Officer of the acquiring corporation) will not constitute Good Reason;</font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="text-indent:20.464%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">A material reduction in Executive&#x2019;s base compensation (except where </font><font style="color:#3a3a3a;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">there </font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">is a reduction applicable to all similarly situated executive officers generally); provided, that a reduction of less than ten percent (10%) will not be considered a material reduction in base compensation;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.464%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">A material change in the geographic location of Executive&#x2019;s primary work facility or location; provided, that a relocation of less than thirty-five (35) miles from Executive&#x2019;s then-present work location will not be considered a material change in geographic location; or</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20.464%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:20%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">A material breach by the Company of a material provision of this Agreement or a failure of a successor entity in the Change of Control to assume this Agreement;</font></div></div>
  <p style="margin-left:1.867%;text-indent:13.909%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.176%;text-align:left;"><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive will not resign for Good Reason without first providing the Company with written notice within sixty (60) days of the event that Executive believes constitutes &#x201c;Good Reason&#x201d; specifically identifying the acts or omissions constituting the grounds for Good Reason and a reasonable cure period of not less than thirty (30) days following the date of such notice during which such condition must not have been cured.</font></p>
  <div class="item-list-element-wrapper" style="text-indent:13.643%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:13.333%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 409A.</font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#3a3a3a;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#3a3a3a;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section </font><font style="color:#232323;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">409A</font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#232323;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">means Code Section 409A, and the final regulations and any guidance promulgated thereunder or any state law equivalent.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.643%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:13.333%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(g)</font><div style="width:100%;display:inline;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 409A Limit.</font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> &#x201c;</font><font style="color:#232323;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 409A Limit</font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#232323;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">will mean two (2) times the lesser of: (i) Executive&#x2019;s annualized compensation based upon the annual rate of pay paid to Executive during the Executive&#x2019;s taxable year preceding the Executive&#x2019;s taxable year of his or her separation from service as determined under Treasury Regulation Section 1.409A-l(b)(9)(iii)(A)(l) and any Internal Revenue Service guidance issued with respect thereto; or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(l 7) of the Internal Revenue Code for the year in which Executive&#x2019;s separation from service occurred.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.821%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:6.667%;text-align:justify;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;"><font style="color:#232323;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Successors</font><font style="color:#232323;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.643%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:13.333%;text-align:justify;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Company&#x2019;s Successors.</font><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company&#x2019;s business and/or assets will assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term &#x201c;Company&#x201d; will include any successor to the Company&#x2019;s business and/or assets which executes and delivers the assumption agreement described in this Section 7(a) or which becomes bound by the terms of this Agreement by operation of law.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.643%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:13.333%;text-align:justify;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s Successors.</font><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> The terms of this Agreement and all rights of Executive hereunder will inure to the benefit of, and be enforceable by, Executive&#x2019;s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">8.</font><div style="width:100%;display:inline;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Arbitration.</font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="text-indent:13.624%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2.13%;min-width:13.333%;text-align:justify;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Arbitration.</font><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> In consideration of Executive&#x2019;s employment with the Company, its promise to arbitrate all employment-related disputes, and Executive&#x2019;s receipt of the compensation, pay raises and other benefits paid to Executive by the Company, at present and in the future, Executive agrees that any and all controversies, claims, or disputes with anyone (including the Company and any employee, officer, director, stockholder or benefit plan of the Company in their capacity as such or otherwise) arising out of, relating to, or resulting from Executive&#x2019;s employment with the Company or termination thereof, and which are subject to arbitration, including any breach of this Agreement, will be resolved through binding arbitration under the Arbitration Rules set forth in California Code of Civil Procedure Section 1280 through 1294.2, including Section 1281.8 (the </font><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">&#x201c;</font><font style="color:#242424;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Act</font><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">&#x201d;</font><font style="color:#242424;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">), </font><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and pursuant to California law. The Federal Arbitration Act shall also apply with full force and effect, notwithstanding the application of procedural rules set forth under the Act.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.605%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.333%;text-align:justify;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#242424;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Dispute Resolution.</font><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#242424;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Disputes that Executive agrees to arbitrate, and thereby agrees to waive any civil action and right to a trial by jury, include any statutory claims under local, state, or federal law </font><font style="color:#242424;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(except those which are expressly excluded by statute, state law, or applicable court decision from being resolved by mandatory arbitration), including, but not limited to, claims under Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act of 1990, the Age Discrimination in Employment Act of 1967, the Older Workers Benefit Protection Act, the Sarbanes Oxley Act, the Worker Adjustment and Retraining Notification Act, the Family and Medical Leave Act, the California Family Rights Act, claims of harassment, discrimination, and wrongful termination, and any statutory or common law claims. Additionally, Executive and the Company voluntarily agree to arbitrate any claims under the California Fair Employment and Housing Act and the California Labor Code. Executive further understands that this Agreement to arbitrate also applies to any disputes that the Company may have with Executive.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Procedure.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive agrees that any arbitration will be administered by the Judicial Arbitration &amp; Mediation Services</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Inc. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">JAMS</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">)</font><font style="color:#4b4b4b;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">pursuant to its Employment Arbitration Rules &amp; Procedures (the &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">JAMS Rules</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">). </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The arbitrator shall have the power to decide any motions brought by any party to the arbitration, including motions for summary judgment and/or adjudication, motions to dismiss and demurrers</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and motions for class certification, prior to any arbitration hearing. The arbitrator shall have the power to award any remedies available under applicable law, and the arbitrator shall award attorneys&#x2019; fees and costs to the prevailing party, except as prohibited by law. The Company will pay for any administrative or hearing fees charged by the administrator or JAMS</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and all arbitrator&#x2019;s fees, except that Executive shall pay any filing fees associated with any arbitration that Executive initiates, but only so much of the filing fee as Executive would have instead paid had Executive filed a complaint in a court of law. Executive agrees that the arbitrator shall administer and conduct any arbitration in accordance with California law</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">including the California Code of Civil Procedure and the California Evidence Code</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and that the arbitrator shall apply substantive and procedural California law to any dispute or claim</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">without reference to the rules of conflict of law. To the extent that the JAMS Rules conflict with California law, California law shall take precedence</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The decision of the arbitrator shall be in writing. Any arbitration under this Agreement shall be conducted in Sacramento County</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">California</font><font style="color:#5e5e5e;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Remedy.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Except as provided by the Act, arbitration shall be the sole</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">exclusive, and final remedy for any dispute between Executive and the Company. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Accordingly, </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">except as provided by the Act and this Agreement, neither Executive nor the Company will be permitted to pursue court action regarding claims that are subject to arbitration. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notwithstanding, the arbitrator will not have the authority to disregard or refuse to enforce any lawful Company policy, and the arbitrator will not order or require the Company to adopt a policy not otherwise required by law that the Company has not adopted.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Administrative Relief.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive is not prohibited from pursuing an administrative claim with a local, state</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">or federal administrative body or government agency that is authorized to enforce or administer laws related to employment, including, but not limited to</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Department of Fair Employment and Housing</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Equal Employment Opportunity Commission</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the National Labor Relations Board, or the Workers&#x2019; Compensation Board. However, Executive may not pursue court action regarding any such claim</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">except as permitted by law.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Voluntary Nature of Agreement.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive acknowledges and agrees that Executive is executing this Agreement voluntarily and without any duress or undue influence by the Company or anyone else</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive further acknowledges and agrees that Executive has carefully read this Agreement and that Executive has asked any questions needed for Executive to understand the terms</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">consequences and binding effect of this Agreement and fully understands it</font><font style="color:#4b4b4b;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">including that </font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">EXECUTIVE IS WAIVING EXECUTIVE&#x2019;S RIGHT TO A JURY TRIAL. </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Finally, Executive agrees that Executive has been provided an opportunity to seek the advice of an attorney of Executive&#x2019;s choice before signing this Agreement.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.784%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:6.667%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">9.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Confidential Information.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> Executive agrees to comply with and be bound by the Employee Confidentiality and Intellectual Property Rights Agreement (the &#x201c;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Confidential Information Agreement</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">entered into by and between Executive and the Company, dated August 20, 2024. Notwithstanding the foregoing, Executive is not prevented from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct Executive has reason to believe is unlawful. </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">10.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notice</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.733%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:13.731%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.402%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">General</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Notices and all other communications contemplated by this Agreement will be in writing and will be deemed to have been duly given when personally delivered or when mailed by U.S. registered or certified mail, return receipt requested and postage prepaid. In the case of Executive, mailed notices will be addressed to him or her at the home address which he or she most recently communicated to the Company in writing. In the case of the Company, mailed notices will be addressed to its corporate headquarters, and all notices will be directed to the attention of its General Counsel.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.733%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:13.731%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.402%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notice of Termination</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Any termination by the Company for Cause or by Executive for Good Reason will be communicated by a notice of termination to the other party hereto given in accordance with Section 10(a) of this Agreement. Such notice will indicate the specific termination provision in this Agreement relied upon, will set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination under the provision so indicated, and will specify the termination date (which will be not more than thirty (30) days after the giving of such notice). The failure by Executive to include in the notice any fact or circumstance which contributes to a showing of Good Reason will not waive any right of Executive hereunder or </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="min-height:0.9in;"></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:13.731%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">preclude Executive from asserting such fact or circumstance in enforcing his or her rights hereunder.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:11pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">11.</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Miscellaneous Provisions.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.605%;font-size:0;margin-top:11.65pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">No Duty to Mitigate.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#4f4f4f;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">will not be required to mitigate the amount of any payment contemplated by this Agreement, nor will any such payment be reduced by any earnings that Executive may receive from any other source.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.605%;font-size:0;margin-top:11.3pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Waiver.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> No provision of this Agreement will be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party will be considered a waiver of any other condition or provision or of the same condition or provision at another time.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12.15pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Headings.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.568%;font-size:0;margin-top:12.15pt;justify-content:flex-start;margin-bottom:0;margin-right:1.731%;min-width:13.333%;text-align:justify;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Entire Agreement.</font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> This Agreement constitutes the entire agreement of the parties hereto and supersedes in their entirety all prior or contemporaneous</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">representations, understandings</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">undertakings or agreements (whether oral or written and whether expressed or implied) of the parties with respect to the subject matter hereof, including, without limitation, any severance provisions contained in the </font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">E</font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">mployment Agreement. Executive acknowledges and agrees that this Agreement encompasses all the rights of Executive to any severance payments and/or benefits based on the termination of Executive&#x2019;s employment and Executive hereby agrees that he or she has no such rights except as stated herein. No waiver</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">alteration</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">or modification of any of the provisions of this Agreement will be binding unless in writing and signed by duly authorized representatives of the parties hereto and which specifically mention this Agreement.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.469%;font-size:0;margin-top:11.1pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.204%;text-align:justify;"><font style="color:#2b2b2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.93%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#2b2b2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Choice of Law.</font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> The validity, interpretation</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">construction and performance of this Agreement will be governed by the laws of the State of California (with the exception o</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">f </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">its conflict of laws provisions).</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.605%;font-size:0;margin-top:12.05pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.333%;text-align:justify;"><font style="color:#2b2b2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#2b2b2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Severability.</font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> The invalidity or unenforceability of any provision or provisions of this Agreement will not affect the validity or enforceability of any other provision hereof, which will remain in full fo</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">r</font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ce and effect.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.605%;font-size:0;margin-top:11.65pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.333%;text-align:justify;"><font style="color:#2b2b2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(g)</font><div style="width:100%;display:inline;"><font style="color:#2b2b2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Withholding</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">All payments made pursuant to this Agreement will be subject to withholding of applicable income</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">employment and other taxes</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">as determined in the Company</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">s reasonable judgment.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.605%;font-size:0;margin-top:12.7pt;justify-content:flex-start;margin-bottom:0;margin-right:2%;min-width:13.333%;text-align:justify;"><font style="color:#2b2b2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(h)</font><div style="width:100%;display:inline;"><font style="color:#2b2b2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Counterparts</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">This Agreement may be executed in counterparts, each of which will be deemed an original</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">bu</font><font style="color:#484848;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">t </font><font style="color:#2b2b2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">all of which together will constitute one and the same instrument.</font></div></div>
  <p style="margin-left:1.773%;font-size:10pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.63%;text-align:center;"><font style="color:#2b2b2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">[Signature Page Follows]</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.68in;min-height:0.86in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  www.arcadiabio.com</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:0.7in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:2.013%;text-indent:6.997%;font-size:10pt;margin-top:3.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.898%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">IN WITNESS WHEREOF</font><font style="color:#464954;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">each of the parties has executed this Agreement, in the case of the Company by its duly authorized officer</font><font style="color:#464954;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">on the day and year set forth below.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:10.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:2.08%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">COMPANY	ARCADIA BIOSCIENCES, INC.</font></p>
  <p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:41.96%;text-indent:-0.054%;padding-left:0.027%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">By</font><font style="color:#464954;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">:  </font><font style="color:#464954;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">/s/ THOMAS J. SCHAEFER</font></p>
  <p style="margin-left:41.96%;text-indent:-0.054%;padding-left:0.027%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:41.96%;text-indent:-0.054%;padding-left:0.027%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Name:  </font><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Thomas J. Schaefer	</font></p>
  <p style="font-size:10pt;margin-top:0.6pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:41.987%;text-indent:-0.054%;padding-left:0.027%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Title:  </font><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Chief Executive Officer	</font></p>
  <p style="margin-left:41.987%;text-indent:-0.054%;padding-left:0.027%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Date:  </font><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">August 20, 2024	</font></p>
  <p style="margin-left:42.013%;font-size:10pt;margin-top:3.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:2.08%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">EXECUTIVE	MARK KAWAKAMI</font></p>
  <p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:41.96%;text-indent:-0.054%;padding-left:0.027%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">By</font><font style="color:#464954;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">:  </font><font style="color:#464954;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">/s/ MARK KAWAKAMI	</font></p>
  <p style="margin-left:41.96%;text-indent:-0.054%;padding-left:0.027%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:41.96%;text-indent:-0.054%;padding-left:0.027%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.389%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Name:  </font><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Mark Kawakami	</font></p>
  <p style="font-size:10pt;margin-top:0.6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:41.987%;text-indent:-0.048%;padding-left:0.027%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.898%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Title:  </font><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Chief Financial Officer	</font></p>
  <p style="margin-left:41.987%;text-indent:-0.048%;padding-left:0.027%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.898%;text-align:left;"><font style="color:#2d2d2d;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Date:  </font><font style="color:#2d2d2d;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">August 20, 2024	</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.7in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">5950 Sherry Lane </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Suite 215  </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Dallas, TX 75225  </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  Tel: 530-756-7077  </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf09f;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">  </font><font><font style="white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:'Arial Narrow',sans-serif;font-style:italic;min-width:fit-content;">www.arcadiabio.com</font></font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Arial Narrow',sans-serif;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img5370606_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img5370606_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" /E!7X# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_<MK-1[JQ_\ 9JY&BL7CL0_M&;Q%5]3J&\?:TPP/LR^XC_\ KTW_ (3O6_\
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M@_A6QUKMA.,U>+N=,9*2NF%%%%6,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>UN[>]@6>UF26)NC(<UZ]'$TZRO!G=3JPJ?"R:BBBMS0**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ I&944LS!5 R23@"J&K:S9Z-;>==R8)^Y&O+.?85YGKOBB^UMRC-Y-KGY8
M4/!_WCW-<F)QE.@K/5]C"K7C3]3J-<\=PV^ZWTH+-)T,[#Y!]!W_ )?6N"N[
MVYO[AI[J9Y93_$Q_EZ5!17@5\34K/WGIV/-J595'J%%%%<YF%%%% !12JI9@
MJ@DGH!6M:>%]:O<&.PE53_%+\@_6KA3E-VBKCC%RV1D45V=K\.[U\&ZO88AZ
M1J7/]*U[?X>Z9'@SW%S*?8A1_+/ZUU0R_$2Z6-HX:J^AYK17KD/@_0H>EB'/
MJ[LW]<5=CT32HON:;:#W\E<_RKHCE53K)&JP4^K/%J*]R6TMD^Y;Q+]$ J55
M"C"@ >@%6LI?6?X?\$KZE_>/"**]W95<8901Z$9J)[2VD^_;Q-]4!H>4OI/\
M/^"'U+^\>&T5[3)H>DR_?TVT/OY*@_GBJ,W@[0IL_P"A;#ZI(P_3.*SEE53I
M)$O!SZ,\DHKTFX^'FG/S!=7$1_VL,/Y#^=8]U\/+^/)MKJ"8>C H3_,?K6$\
MOQ$?LW,I8:HNAQU%:MYX;U>QR9["7:/XD&\?F,UED8-<DH2@[25C%Q<=T)12
MXI*D04444 %%%% !5O3]3O-+N/.LYVB;N!T;V([U4HIQDXNZ!-IW1Z;H?C>T
MU K!?A;6X/ ;/[MC]>WX_G75UX/72:!XON](*P3[KBS'&PGYD'^R?Z?RKU\-
MF?V:WW_YG=1Q?2?WGJE%5=/U&UU2U6XM)A(AZ^JGT([&K5>RFI*Z.Y--7044
M44QA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %<WXC\66^C*UO!MFO2/N9XC]V_PJAXI\8BT+V&FN#<?=DF'2/V'O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/3+>\CX$JY(]#T(_ YKQ*NZ^'NJ8>?3)&X/[V+/KT8?R/X&O2RVMR5>1[/\
M,ZL)4Y9\KZG?4445] >F%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 07MTEC8SW4GW(D+GWP.E
M>)W$\EU<RW$IS)*Y=C[DYKT7X@:A]GTF*R4_-<OEO]U>?YX_*O-:\'-*O-45
M-=#S<9.\N7L7M'TV35]4ALX\@.?G8?PJ.IKV:"".VMXX(5"QQJ%51V KE/ 6
MD?9=.?4)5Q+<\)GL@_Q/\A77UW9=0]G3YWN_R.C"T^6',]V%%%%>@=04444
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M5J'V[P[$C'+VQ,)^@Z?H0/PKHJ^MI5%4@IKJ>W"7-%2"BBBM"@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKU'P'<>=X;6//,$K)^!^;_V:O4RJ=JKCW1UX.5IM'3T445[QZ04444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&7D<-2FX,KD4PBI2*C(KE9D:_AO5/L&H"*1L03D*V?X3V-=]7DYKT+P[J/\
M:&EKO;,T7R/ZGT/XC^M>KEU?>D_D=6'G]EFM1117K'4%%%% !1110 5Y!XAM
M/L6O7L(&%\PLH]FY'\Z]?KSKQ];>7J\%P!Q+#@_4'_ BO-S.%Z*EV9RXN-X7
M[''M333S3#7@'F"5WOPXGRFH6Y/0HX'Y@_R%<%77?#V7;KD\?9[<G\0P_P#K
MUU8&7+B(FV'=JJ/2J***^G/7"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGZ+;?9=+B!&&?YV_'_ZV*T*^@PM/DI)'?3CRQ04445T%A1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5Q6KIY'Q&TN;C$J*,GU^9?\
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MCZ$9J6N;\#WOVKPY'&3EK=VB/TZC]#C\*Z2O)G'EDT:H****D84444 %%%%
M!1110 5P/B>Q^R:JTBC$<_SCZ]_UY_&N^K#\56?VG2#*HR\!WCZ=#_C^%<F-
MI>THONM3*M'F@<":ZGP1-^\O(2>H5P/S!_F*Y5JWO!LFS6V7L\+#]0?Z5XV#
MERUXLXJ+M41WM%%%?2'I!1110 5E>)9/+\-W[>L17\^/ZUJUSWC:7R_#4R?\
M]71/US_2L<1+EI2?DR*KM!L\M:HS4C5&:^4/%$KK_AY%NUFYE[) 1^)8?X&N
M0KT#X<08M[^X(^\Z(/P!)_F*Z\!'FQ$3;#*]5'<4445],>N%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** .!^($>+ZSE[-&R_D?_KUR(-=[\0(-VFVMP!_
MJY2OX,/_ +$5P -?-X^-L1(\O$*U1DH-/!J(&G@UQF)*#3P:B!IP-,HF!KL/
M!+Y%ZF?[A'_CU<8#73^"YMNJ31$_?BR/J"/\379@I6KQ-J#M41W-%%%?1GI!
M1110 4444 %%%% !1110 4444 %%%% 'A?CZ0/XWU(CH#&.?:-17-9K:\9R^
M9XQU1LYQ.5_( ?TK"S7NTE[D?1',]QV:T-"G^S^(--FSC9=1L?IN%9F:='(8
MI4D7JK!A^%6U=6%<^FZ*16#J&4Y!&0:6OGSJ"BBB@ HHHH **** "BBB@ HH
MHH ***SM;U:+1M-DN9,%_NQI_>;L*F4E"+E+9";25V<YXZUORH1I4#_.X#3$
M=E[+^/7_ /77GQ-37-Q+=7$D\SEY9&+,Q[FJY-?+XFNZU1S9X]6HZDN80T45
MH:)I4FL:I%:)D*3F1O[JCJ?\]ZQC%RDHK=D)-NR.Q\ :,8X9-5F7YI,I#G^[
MW/XGC\#7;U'!#';01P0J$CC4*JCL!4E?58>BJ--01[%*"A%104445L:!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!D>*+3[9X<O$ RR)YB_\!.?Y
M UY,#7M[*'4JPRI&"/6O&-2M&T_4[FT;/[J0J">X['\L5XN:T]8U/D<&,CJI
M$0-.!J(&G@UY)QDH-/!J$&G@TRB4&M30+H6FMVLA.%+[#]&X_K62#3@V#D5<
M)N$E)="HNSN>QT52TF]&H:7;W.<LRX?_ 'AP?UJ[7U49*24EU/63NKH****H
M84444 %%%% !1110 4444 %%%% 'SIXDF\[Q/JLF<@W<N/IO.*RMU27LWGW]
MQ-G/F2LV<YZDFJ^:^ABK)(Y6R3=2;J9FC-,1],Z7+Y^D64O/SP(W/NH-6ZR?
M"\GF^%-(?))^QQ D^H0 UK5\_)6DT=2V"BBBI&%%%% !1110 4444 %%%!(
M))P!WH CFFCMX'FF<)&@+,QZ 5Y-XBUR36]0,O*V\>5A0]AZGW-:?BWQ+_:<
MILK1_P#0XS\S#_EJW^ _^O7)DUX./Q?M'[.&R_$\W$U^9\L=@)IM%%>6<@ $
MG Y->K^$M!_L;3=\RXNYP&DS_".R_P"/O7->"/#WVNX&J72?N(C^Y4C[[#O]
M!_/Z5Z-7MY;A;+VTOE_F=^$HV]]A1117KG<%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZC_/->YA\QA4TGH_P/0I8F,M):,ZRBFQR)+&LD;JZ,,AE.0?QIU>B=04444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8Y)IE%>'4JSJ.\W<X93E+XF+FDHHK,D**GM+*ZOYQ#:0/-(>R#./KZ5VVC>
M -LVK29[^1&>/Q;_  _.MZ.&J5G[B-*=*=3X4<AIFCWVKS^59PE\?><\*OU-
M>CZ#X0LM(VSS8N;L<[V'RH?]D?U_E6];V\-K"L-O$D4:]%08 J6O<PV IT?>
MEJST*6&C#5ZL****[SI"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D=%D1D=0RL,%2,@B
MEHH X[6? =M=%IM-<6TIY\IO]6?IW%<+J.DWVE2^7>6[QYZ-U5OH>AKVNF2P
MQSQ-'-&DD;<%7&0?PKSZ^74ZFL-'^!RU,+"6JT9X517INI^ ].NRSV;M:2'L
M/F0_@>GX&N2O_!FLV.66 7,8_B@.X_EU_2O)JX&M3W5UY'%/#U(=#GZ*<Z/&
MY21&1AU5A@BFUQF(49HHH 7-&:2B@!<U8L8#>:A;VP',LJI^9Q5:NB\$VOVG
MQ-"Q&5@5I3^6!^I%:T8<]2,>[*IQYI)'0?%6_&G^ +J-2%:Y>.W3\3N(_P"^
M5-?.N:]?^.6I8&DZ8K?W[AQ^2K_[/7CN:_2L!#EHW[GH5G>0_-)FF9HS7;8R
M'9J6VB-Q=PP#K(ZH,>YQ5?-;7@^W^U^,M&@ZAKR(GZ!@3^@-*3M%L%JSZ,\9
M.(?"EVH&-VQ !_O#^E>35Z9\09MF@11CK).H_  G_"O/[/2=0U @6EG-*#_$
MJ_+^?2OS?,KSK\JUT)Q=Y5+(IT5U]C\/M0FPUY/%;+W5?G;]./UKJ=/\&:/8
M89H#<R#^*<[A^72LJ67UY[JR\R(86I+?0\UT_1]0U1]MG:R2#."^,*/J3Q78
MZ7\/8TVR:I<;S_SQAX'XMU_+%=PJJBA54*HX  P!2UZ='+:4-9ZO\#KIX2$=
M7J5[2RM;" 0VD"0QCL@QGZ^M6***]!))61U)6V"BBBF 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %<1\6-7_LKP%>(K8EO&6V
M3Z-RW_CH8?C7;UX5\<]9\_6K#1XV^6UB,T@'3>_0'W &?^!5TX.GSUHKYF=6
M7+!GE.:3--S1FOI#@'9I,TW-&: '9KZ ^"&G_9_"%U>LN&N[HX/JJ@ ?KNKY
M\S7UCX)TS^Q_!6D617:Z6RNX]';YF_5C7G9E.U)1[LWPZO*YOT445X9V!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5!?7L&G6%Q?74@CM[>)I97/\
M*J,D_D*GKR']H'Q3_9/@^+0[>3%SJKX?!Y$*8+?F=H]QNH \LO/CSXWEOKB2
MUOH(+=Y&:*+[+&VQ2>%R1DX%0_\ "]?'W_04@_\  2+_ .)KS>B@#TC_ (7K
MX^_Z"D'_ ("1?_$T?\+U\??]!2#_ ,!(O_B:\WHH ](_X7KX^_Z"D'_@)%_\
M31_PO7Q]_P!!2#_P$B_^)KS>B@#W[X5?&+7=<\:0Z1XCNXIH+R-D@984CVRC
MD<@<Y (^I%?0-? ]G=SZ??6]Y:R&.XMY%EB<=593D'\Q7W#X6UZ#Q/X7T[6K
M? 2[A#LH_@?HR_@P(_"@#7HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBBB@ KZ(_9HLY$T[Q%>D'RII8(E..Z!R?_1@KYYBB>:5(HD9Y'8*JJ,EB>@
MK[0^&OA0^#? UCIDJ@7; SW6#G]ZW)'X#"_\!H ZVBBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKXKV)I6KPM<-_P NTI\N7_OEN3^&1744 %%%% !1110 4444 %%%% !1110
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M0;F_X#78U\Q?M">*?[3\66^@P29M],3,H!X,S@$_DNT?4F@#QVBBB@ HHHH
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MPQI:PIR!=7OS-]0@.!^)/TKR37O&?B3Q.Y.L:Q=72$Y\HOMC'T084?E6%10
M4444 %%%% !1110 4444 %%%% !1110 5T_A3X@^)?!LP.DZ@XM\Y:TF^>%_
M^ GI]1@^]<Q10!]8> OC5HGBUXK#4%72]6;"K&[9BF/^PW8G^Z?P)KT^O@"O
M<?A3\:9K"6#0?%5R9+)L);W\ART)Z!9#W7_:ZCOQT /HZBD!#*&4@@C(([TM
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% &9XBUNW\.>'=0UBZQY5I"TNW.-Q ^5?J3@?C7PYJ%]<:IJ5U?W;[[BY
ME::5O5F.3^IKW_\ :,\4^38Z?X7MY/FG/VJZ /\  #A!^+;C_P !%?.] !11
M10 5-9VD]_?6]G;1F2XN)%BB0=69C@#\S4->L_ #PQ_;'C=]7FCW6VDQ^8,C
M@S-D)^0W'Z@4 ?2/AK0X/#7AK3M&M\>7:0+&6 ^\W\3?BQ)_&M6BB@ HHHH
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MQ[V0++?39CL[<G_6/ZG_ &1U/X#O7QWJVJWNN:K<ZGJ-PT]W<.7DD;N?Z =
M.PH =K&LZAK^J3ZEJEU)<W<S9=W/Z =@.P' JC110 4444 %%.1'DD6.-6=V
M("JHR23V KVGP+\ +[5$CO\ Q5))I]LWS+91X\]Q_M$\(/;D_2@#QNTL[K4+
ME+:RMIKF=SA8H8R[-] .37HFA_ GQKJZK)/:V^F1-WO)<-C_ '5!(^AQ7T[H
M'A?1/"]F+71=-@M(\88HN7?_ 'F/+?B:UZ /!M._9JM54'4_$<TA[I;6X3'_
M  )B<_E706_[/'@N''F3ZM/@\^9<(,_]\H*]9HH \N?X >!V0@1:@I/\0NN1
M^8K-O/V<?"\H)M-4U6!C_?>.11^&T']:]CHH ^<-6_9MU:%2VD:[:77<)<Q-
M"?ID;@?TKS;Q%\//%?A8-)JNC7$<"];B,"2+'NRY _'!K[8H(!!!&0>H- 'P
M!17USXQ^"_A?Q2DD]M;KI6HG)%Q:H K'_;3H?J,'WKYO\9_#_7O UZ(M4M]U
MLYQ#=PY:*3VSV/L<'\.: .6JQ87]UI>H07UE.\%U;N)(I$."K#H:KT4 :_BC
M7YO%/B.[UJYB2*>Z*ET0_+D(%)'UQG\:R*** "BBB@ KV?\ 9N_Y'+5O^P?_
M .U$KQBO9_V;O^1RU;_L'_\ M1* /IBBBB@ KY@_:._Y*'I__8*C_P#1LM?3
M]?,'[1W_ "4/3_\ L%1_^C9: /'Z*** "BBB@#TCX%?\E7TW_KE/_P"BVKZW
MKY(^!7_)5]-_ZY3_ /HMJ^MZ "BBB@ JCK6DVVNZ)>Z5>+FWNX6A?U (QD>X
MZCZ5>HH ^#-6TRYT75[S3+M=MQ:3-#(.V5../:J=?07QC^%NL>(/&]GJ7AZQ
M,YOXMMTVX*L;I@!F)X *D#U^4U>\*_LZZ9:!+CQ-?/?3=3;6Q,<0]BWWF_#;
M0!\Z6UK<7MPEO:P2SS.<+'$A9F/L!R:[S1?@KXYUD*_]E"PB;^.^D$6/JO+_
M /CM?5FC^']'\/VWV?2--M;*/&"(8PI;ZGJ?QK2H ^?M+_9J<A6U?Q&H/>.T
MM\_^/L?_ &6NLL/V??!5H!]H_M&]/?SKC:/_ !P+7JM% '%6WPC\!6@ C\-V
MS8_YZN\G_H3&M*+X?^#8@0OA71CG^_91M_,5T=% '/\ _"">#_\ H5-#_P#!
M=#_\35.Y^&7@BZ!$GAC35R23Y4(C_P#0<5UE% 'F.I_ 3P-?*WV>VO-/8\YM
MKDG]'W5Y[X@_9QU6U1YM U:"^4<B"Y7RG^@894GZ[:^D** /A+6M U;P[?&S
MUC3Y[.<=%E7 8>JGHP]QD5FU]VZYH&E>)-->PU>QBN[9_P"&0<J?53U4^XKY
M:^*'PHO/ MQ]NLFDN]#E;"3$?- 3T5\?HW0^U 'F]%%% !1110!]!? GXE/(
M8_!^L3EB!_Q+IG/8<F(G_P!!_+T%>^U\"6]Q+:W,5Q;R-'-$X>-U."K Y!'N
M#7VE\//%L?C3P;9ZKE1<X\JZ1?X95^]] >&'LPH ZFBBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9--';P23S.J11J7=V.
MH R2:?7E_P =O%7]@>!'T^"3;>:LQMUQU$0YD/Y87_@= 'S?XU\22>+/&&I:
MRY;9/*?)4_PQCA!_WR!^.:P*** "BBB@ K[ ^#GAC_A&?AY8B6/;=W_^F3YZ
MC>!M'X+MX]<U\T?#KPR?%OCK3=+="UL9/-N<=HEY;\_N_4BOM8    8 Z 4
M%%%% !1110 4444 ! (((R#U!KXK^)'A@^$?'6I:8B%;4OYUKQP8GY4#Z<K]
M5-?:E>*?M$^%_MWA^S\201YFL'\F<@=8G/!/T; _X&: /FNBBB@ HHHH ]D_
M9Z\4_P!F>*;CP_<28M]33=%D\"9 3^JY_$"OINO@G3K^XTO4K74+1]EQ;2K-
M$WHRG(_E7W'X=UJW\1^';#6+4_NKN%9 ,_=)ZJ?<'(_"@#3HHHH **** "BB
MB@ KP#]IK_F5_P#M[_\ :->_UX/^TO\ \@_P[_UUG_DE 'SQ1110 4444 />
M62145Y&8(-J!CG:,YP/09)IE%% "HC2.J(I9V.%51DD^@KW_ .&GP*0Q0ZSX
MOB)+ /#IIXP.QE_^)_/N*N?!#X7I9V\'BW6X,W4HWV$#CB-3TD(_O'MZ#GJ1
MCW.@!D,,5M D$$2111J%2-%"JH'0 #H*?110 4444 %%%% !61XF\1V'A3P_
M=:QJ+[8(%R%'WI&/W57W)_QZ5KU\I_&_QV?$_B<Z/93;M*TQR@VGB6;HS^X'
MW1^)[T <-XK\4:CXO\07&L:E)F64X2,'Y8D'W47V'Z\D\FL6BB@ HHHH *GL
M[.YU&]AL[."2>YF<)'%&,LS'H *9;V\UU<Q6]O&TLTK!(XT&2S$X  ]:^LOA
M3\+[?P1IJWU_''-KMPN9),9^SJ1_JU/\R.OT% &)\-_@=8Z)'#JGB>.*]U,@
M.EJ?FAMS[]G;]!VSP:]DZ# HHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KCOB5X&M_'/A6:SV(N
MHP RV4QZK)C[I/\ =;H?P/:NQHH ^ YHI()I(9D9)8V*NC#!4C@@TRO3?CMX
M>71/B--=0IM@U.);H8Z!^5?\21N_X%7F5 !1110 5]9? OQ*=>^'T5G,Y:YT
MM_LK9/)CQF,_3!V_\!KY-KV']G7639>-KS2F;$6H6I(&>LD9R/\ QTO0!]/4
M444 %5[^^MM,T^XO[R58K:WC:661NBJ!DFK%>#?M#^-##;V_A&SEPTH%Q>E3
M_#GY$/U(W'Z+ZT >0>/?&5WXX\47&J3[DMP?+M8">(H@>!]3U/N:YBBB@ HH
MHH *GL[.YU&]AL[."2>YF<)'%&,LS'H *@KZA^"?PU3P[I4?B+5(0=6O(\PH
MXYMHB/T9AU]!QZT 7OA?\([+P=;Q:GJB1W6O.N=QPR6W^RG^UZM^7'7U"BB@
M HHHH **** "BBB@ HHHH *JZEIEEK&GS6&HVL=S:3+MDBD7(8?Y[U:HH ^2
MOBG\*KGP/>&_T\27&A3-A)#RUNQ_@?V]&[].O7S6OO;4=.M-6TZXT^_@2>UN
M$,<L;CAE/^>M?&GQ#\%7'@;Q7/ICEI+1_P![:3'_ ):1$\9_VAT/TST(H Y2
MBBB@ HHHH *]G_9N_P"1RU;_ +!__M1*\8KV?]F[_D<M6_[!_P#[42@#Z8HH
MHH *^8/VCO\ DH>G_P#8*C_]&RU]/U\P?M'?\E#T_P#[!4?_ *-EH \?HHHH
M **** /2/@5_R5?3?^N4_P#Z+:OK>ODCX%?\E7TW_KE/_P"BVKZWH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ JMJ&GVNJZ?<6%] D]K<(8Y8
MW'#*:LT4 ?$_C_PC-X)\77>D.6> ?O;:5O\ EI$WW3]1R#[@US%?3/[17AY+
MWPG9Z[&@\_3YQ'(V/^64G'/T8+CZFOF:@ HHHH *]F_9W\3&P\576@328@U*
M+S(@3P)D!/'U7=_WR*\9K6\,:PV@>*=+U921]DN8Y6QW4$;A^(R/QH ^Z:*0
M$,H92"",@CO2T %%%% !1110 4444 %%%% !1110 4444 %%%% !115>]O[/
M3;5[J^NH+6W3[TL\@11]2>* +%%>8:]\>?!FD;H[.>XU6<<;;6/" ^[M@8]Q
MFO--;_:,\17FY-(TZRTZ,]'?,\@_$X7_ ,=- 'TU67J7B70M&S_:>L6%F?[L
M]PB'\B<U\;ZOX_\ %NN[AJ/B"_E1NL:RF-#_ , 7"_I7.=30!]?:A\;/ 5AD
M#63<N/X;>WD;]<!?UKYY^*GCE/'?BS[;:"9-.MXEAMDE&&QU9B 2 2Q/X 5P
M]% !1110 4444 >F?"/Q[X>\ W&HW>JV5_/=W*K%&]LB,$0')'S,O4X_[Y%>
MPVW[0'@>?'F2:A;9_P">MMG'_?)-?*5% 'V59?%OP'?D"'Q):H?^FZO#_P"A
MJ*Z:PUO2=5&=.U2RO!_T[W"2?^@DU\'TH)5@RD@CD$=J /OZBOB/2O'WBW12
MOV#Q#J$:+TC:8R(/^ MD?I7=Z-^T1XJLBJZG:6.I1CJ2AAD/XK\O_CM 'U#1
M7DFA_M">%-1VQZG#>:5*>K.GFQC_ ($O/_CHKTO2==TG7;<SZ3J5K>QCJ;>4
M/M^H'0_6@#0JCK.E6VN:+>Z5=KFWNX6A?V!&,CW'6KU% 'P9JVF7&BZQ>:9=
MKMN+29H9 .F5.,CVJG7M'[1'A?[!XDM/$4"8AU%/*G('29!@'\5Q_P!\FO%Z
M "BBB@ KZ)_9S\4^=8:AX7N'^> _:K4'^X2 Z_@V#_P(U\[5O^"O$DGA/QAI
MNLH6V02CSE'\49X<?]\D_CB@#[@HID,T=Q!'/"ZO%(H='4Y# C((I] !1110
M 4444 %>#_M+_P#(/\._]=9_Y)7O%>#_ +2__(/\._\ 76?^24 ?/%%%% !1
M110 5W_PB\$#QIXRC6ZCW:78@3W>>C\_+'_P(C\@U<!7UK\#O#2Z#\.[:ZD3
M%UJC?:Y"1SL/$8^FW!_X$: /20 JA5   P .U+110 4444 %%%% !1110!Q'
MQ7\7'P?X%N[J"3;?W/\ HUI@\AV!RP_W5R?J!ZU\;]37KW[0GB,ZGXUAT:)\
MP:7" P!X\UP&;_QW8/SKR&@ HHHH ***V?"GA^?Q3XIT[18,AKJ8*S ?<0<N
MWX*"?PH ]G^ /P_4I_PF.I0Y)+)IZ,.G9I?YJ/Q/I7O]5[&QMM,L+>QLXEBM
MK>-8HHUZ*H& *L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'A7[2MB'TK0-0 ^:*>6
M GUW*&'_ * :^=:^GOVCU4_#_3GP-PU2, ^QBE_P%?,- !1110 5UOPPOSIW
MQ.\.S@XW7B0YSVD_=G_T*N2J_H=Q]D\0:;<@D&*ZBDR!GHX- 'WA1110!#>7
M<-A93WERX2""-I9'/\*J,D_D*^'/$^NW'B;Q+J&LW.?,NYBX4G.Q>BK^"@#\
M*^G/CMKIT?X;3VT;[9M2F6U&.NW[S_AA<?\  J^3: "BBB@ HHHH ](^"_@I
M?%OC);B[BWZ9IFV><,,K(^?D0_4@D^RD=Z^MZX'X.>&1X:^'=CYB;;N_'VR<
MGK\X&T?@NWCUS7?4 %%%% !1110 4444 %%%% !1110 4444 %>:_&[PFOB/
MP'->11YOM*S<Q$#DIC]XO_?(W?517I5-EC2:)XI%#1NI5E/0@]10!\!45H:]
MIIT;Q#J6EMG-G=2P9/?:Q&?TK/H **** "O9_P!F[_D<M6_[!_\ [42O&*]G
M_9N_Y'+5O^P?_P"U$H ^F**** "OF#]H[_DH>G_]@J/_ -&RU]/U\P?M'?\
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M9=1\06$4B]8EE#N/^ +EOTKY!UOQMXF\1;AJVN7MS&W6(R%8_P#OA<+^E8-
M'U/J?[0O@VS++9QZAJ#=FBA"*?Q<@_I7)7_[2UPV5T[PU$GH]Q=%\_\  54?
MSKP6B@#U:]_:$\:W)/D+IMH.WE6Y8C_OMC6%=?&/Q_=YW^(ID'I%#%'C_OE1
M7#44 ='/X_\ &-SGS?%&L8(((6]D4$'V!K/E\1Z[,P:76M1D(& 6NG/]:S**
M +!O[PYS=SG/7,AJO110 4444 %%%% !5BP_Y"%M_P!=5_F*KU8L/^0A;?\
M75?YB@#[WHHHH ^</VD]5,OB#1M)5OEM[9KA@/5VVC/X1_K[UX?7H7QNO3>?
M%?5AG*6XBA7\(U)_4FO/: "BBB@ K8\*Z1_;_BS2=)P=MU=1QOCLA8;C^ R:
MQZ].^ FGB]^*-M,5R+.VFGY[<;/_ &>@#ZP551 B*%51@ #  I:** "BBB@
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M?U27)R?,O)&R?Q-9%% %N35-0F;=+?7+MC&6F8G^=5I)'E<O([.Q[L<FFT4
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M'P#]1@^] 'R5177^,OAKXC\$REM1M/-LBV$O8,M$?3)ZJ?8X]LUR% !1110
M4444 %%%%  "000<$=#7VG\-O% \7>!-.U)W#72IY%USD^:G!)^O#?\  A7Q
M97L_[//BK^S_ !+=>';B3$&HIYD /03(,X'U7/\ WR* /IBBBB@ HHHH *^?
M_P!IK_F5O^WO_P!HU] 5\_\ [37_ #*W_;W_ .T: / **** "BBB@#KOA:JO
M\3_#P8 C[8IY]0"17VC7QA\*_P#DJ'A[_K['\C7V?0 4444 %%%% !1110 5
MYW\<9C#\)M65>/,>!,Y[>:A_I7HE>8?'W_DET_\ U]P_S- 'R?1110 4444
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M?4)+'3$/599?,D'X)D?^/4 >345](Z;^S9HT0!U/7;ZY;N+>-(1].=U=39?
M[P#9@;])DNF'\4]U(?T4@?I0!\BT5]LVWP[\&6F/*\+Z3D=#):HY'XL#6K!H
M&C6N/L^D6$6#D>7;(N/R% 'PC4D5O--GRH9),==BDXK[XCACA7;%&D:DYPJ@
M#-/H ^!S8W8!)M9P!U)C-05]_P!?!%__ ,A"Y_ZZM_,T 5Z*** "BBB@#ZW^
M!7_)*--_ZZS_ /HQJ](KS?X%?\DHTW_KK/\ ^C&KTB@ HHHH **** "BBB@
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MYA['L?4'D?3!H YBBBB@ HHHH *MZ9J-SI&JVFI6C[+FUE6:-O1E.1^%5**
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M ?8U%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\<?&#_ )*OK_\
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M?^NK?S- %>BBB@ HHHH ^M_@5_R2C3?^NL__ *,:O2*\W^!7_)*--_ZZS_\
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M=_R4/3_^P5'_ .C9: /'Z*** "BBB@#TCX%?\E7TW_KE/_Z+:OK>ODCX%?\
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MHHHH **** /K?X%?\DHTW_KK/_Z,:O2*\W^!7_)*--_ZZS_^C&KTB@ HHHH
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MO^WO_P!HU] 5\_\ [31&[PNN1D"[)'_?F@#P"BBB@ HHHH [#X5_\E0\/?\
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MF)8GU)K[]KX.UNR.FZ]J-BR[3;74L)&,8VL1_2@"C1110 4444 ?3W[.#J?
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MZ$ 'V'1532]4LM:TV#4=.N4N+2X7?'*AX(_H>Q'4&K= !1110 4444 %%%%
M!1110 444=!DT -=TCC:21E1%!+,QP !W)KY!^+?CO\ X3;Q6QM9"=)L<PV@
M[/S\TF/]H@?@!79_&3XNKJ:W'ACP[/FRR4O+Q#_KO6-#_<]3_%TZ=?#: "BB
MB@ HHHH *]G_ &;O^1RU;_L'_P#M1*\8KV?]F[_D<M6_[!__ +42@#Z8HHHH
M *^8/VCO^2AZ?_V"H_\ T;+7T_7S!^T=_P E#T__ +!4?_HV6@#Q^BBB@ HH
MHH ](^!7_)5]-_ZY3_\ HMJ^MZ^2/@5_R5?3?^N4_P#Z+:OK>@ KY0^/Q)^*
M$V3TM(<?D:^KZ^6_VB+)K?XB6]SCY+FPC;/NK,I'Y ?G0!Y)1110 4444 >I
M_L_3)%\30C'F6RF1>>_RM_)37U97Q-\/==3PWX_T;5)6V0Q7 29O2-P48_@&
M)_"OMGJ,B@ HHHH **** "BBB@ HHHH ***IZKJMEHFE7.I:C<+!:6Z%Y)&[
M#V]2>@'4GB@#A_C1XKC\-> +J!) +W4U:T@7/.TC]XWX*<9]6%?(E=7\0O&M
MUXZ\43:E*&CM4'E6D!/^KC!XS_M'J??V KE* "BBB@ HHHH ^M_@5_R2C3?^
MNL__ *,:O2*\W^!7_)*--_ZZS_\ HQJ](H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "@D $DX ZDT5YY\9_%/_  C/P^NDA?;>:B?LD.#R P.]OP7(
MSZD4 ?-WQ'\4'Q=XZU'5%<M:[_)M?01)PN/KRWU8URE%% !1110 5[;^SKX7
M^V:[?>))X\Q6*>1;DCK*X^8CZ+Q_P.O$@"2 !DGH*^U/AOX8_P"$2\":;ICI
MMNBGG77KYK\L#].%_P" B@#JZ*** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH S?$.BV_B+P]?Z/=#]U=PM$3_ '21PWU!P?PKX;U"PN-+U*ZT
M^Z39<6TK0RKZ,I(/ZBOO:OF#]H/PO_97BZ#7($Q;ZI'^\P.!,@ /YKM/N<T
M>/T444 %%%% 'M?[._BK[#X@N_#<\F(=07SK<$\"9!R!]4S_ -\"OI2O@S2=
M3N=%U>SU.T;;<6DRS1GME3GGVK[ET75K;7=$LM5LVS;W<*S)Z@$9P?<=#]*
M+U?._P"TO_R$?#O_ %RG_FE?1%?._P"TO_R$?#O_ %RG_FE 'A%%%% !1110
M!V'PK_Y*AX>_Z^Q_(U]GU\8?"O\ Y*AX>_Z^Q_(U]GT %%%% !1110 4444
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MR3\<= ;1?B3=W"IBWU)%NHSVR1AQ]=P)_$5]7:?>PZEIMK?VYS#<PI-&?56
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M 'R3FMN*:*=-\,B2+G&48$?I0 ^BD)"J68@ #))[5EWOB?0--!-]K>G6V/\
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M?HHHH **** /2/@5_P E7TW_ *Y3_P#HMJ^MZ^2/@5_R5?3?^N4__HMJ^MZ
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MV,?]\FOH>B@#C_"GPQ\+>#9EN=+L&:]52OVNXD+R8/!QV''H!78444 %%%%
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MPW20LHWJRD<D8Z;J^EJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3^-/#-M.\$^NV$4L;%71Y@&4CJ"#TJHQE+97$VEN;M%<]_PG?A3_ *&'3O\
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MZL@]%FCQ^J5-X>^%<7A3QA9ZMIFH2RVBK(DL-QC>,J0""H /..,"O1B0H))
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M^/ZW_P"NB_SK[,KXSL_^/ZW_ .NB_P Z^S*US7>'S_0G#=0HHHKR3I"BBB@
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MX(\=ZAX,U#='NGT^4_O[0M@-_M+Z-[]^AKV+XC?#.#Q1%)J>F*L.L(O(Z+<
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MZ\)2:LBE\!_^1IU+_KR_]G6O:]4\0:1HL32:EJ5K;!1G$D@#'Z+U/X"O(?\
MA0=U_P!#!#_X"G_XJC_A0=U_T,$/_@*?_BJ*ZPU:ISNI^#%#VD(VY3E_B;XY
MB\8ZM!'8HRZ=9AA$SC#2,V,L1V' P/\ ' XRRLKG4;V&SLX'GN9F"1QH,EC7
MMMC\!+"-P;_7+F=<_=@A6+]26KT#P[X-T+PM&1I=BL<K##SN=\C?\"/0>PP*
MV^O4*,.2EK8GV,Y.\@\&: ?#/A*PTIV#31(6E(.1O8EFQ[ G'X5O445X\I.4
MG)[LZDK*R"BBBI&%%%% !1145R)S;2"V:-9RIV-("5!]2!U% 'Q_K'_(;O\
M_KYD_P#0C73_  E_Y*=H_P#VV_\ 1+UV,OP'O9YGED\10L[L68_93R3R?XJT
MO#?P?U'PUXAL]8M]<MY)+9B=CVQPP*E6'WN.">:]ZIBZ$J3BI:V\SBC2FI)V
M/6Z***\$[0HHHH **** "@@$$$9!HHH \ ^(_P +;G2KF;5]"@>?3G)>6WC&
M6MSWP!U3^7TYKS?2]3N]&U.WU&QE,5S;OO1A_(^H(R"/0U]CUQ_B+X9>&?$<
MC3S69M;IN3/:$(2?<8*GZXS[UZM#,+1Y*JOY_P"9S3H:WB5_"7Q0T+Q);QQW
M%Q'I^H8P]O.X4,?]ACPWTZ^W>NW#*RA@05(R"#QBO$K[X"7 8G3]=B=>RW$!
M4C\03G\JSQ\#O% S$-4TP0$\CS9>?PV8K*=#"R=X5+?(I3J+>)ZAXI^(V@>&
M+:3==QW=Z.$M+=PS9_VB.%'U_(U\V:[K=YXBUFXU2_?=/.V<#HH[*/8#BO4K
M'X"73,#?Z["B]U@@+D_B2,?E7<Z!\*?"^@NLWV1KZY7D2WA#X/LN OZ9]ZVI
M5L-ADW%\S)E&I4WT1Y5\._AC=>([F+4M5B>#1U(8!N&N?8>B^I_+U'T2B+&B
MHBA44 *JC  ]!3NE%<.(Q$J\KRV-H4U!604445SEA1110 4444 <S\0PQ^'V
MM[021;$\?45R?P\^*EEJ=C#I>O7*6VHQ@(L\IPDX[$GH&^O7MUQ7I&IZ?!JV
MF7.GW08P7,;12!3@X(P<&O*=1^ ME(Q;3-:G@'9+B(2?J"O\J[*$J#ING5=M
M=&934U*\3U\$, 000>017.>-?%6G>&-!N9;J:,W+Q,L%OGYI&(P./3U->8I\
M'?&-C&8M/\1V\<9XVBXFB!'T"FF6_P "M9N9_,U/7+52QR[QJ\K'_OK;5PH8
M>+O*I=>@G.;5E$\C +$  DG@ 5])_"?PG/X9\,O-?1F.^OW$LD9ZQH!\JGWY
M)/UQVJSX6^%_A_PO*ETL3WM\O(N+G!V'_97H/KR?>NUJ\9C557)#8FE1Y7=A
M1117FG0%%%% !1110 5Y9\3_ (9OK[MK>BHO]HA?W\'3SP.A!_O <>X]QSZG
M16M*K*E+FB3**DK,^,9X)K6=X+B)XIHV*O&ZE64^A!Z5[)X#^,,,%I#I?B9G
M'E@)%? %L@=!(!SG_:'X^M>F>(?!F@^*%_XFFGQR3 86=/DD7_@0Y/T.17G.
MI? 6!G+:7K<D:]H[J$/_ ./*1_*O3EB\/B(\M70YU3G!WB>KZ?J^FZM$)=/O
M[:Z0C.890_YXZ5;DECAC:25U1%&2S' 'XUX"_P "O$B.##J6EG'(8R2*0?P0
MU;3X&Z[.0+S7;0*/[H>3'X'%<KP^'Z5=/0T52?\ *=KXK^+6@Z#;R1:?/'J=
M_C")"V8U/JSCC\!D_3K5+X.ZE>ZY;Z]K&H2>9<W-VH9O3"\*!V !P*@TOX%Z
M);,KZEJ-W>D?PH!"A^HY/ZUZ)H^AZ9X?LOLFE645K!G<53JQZ9)/)/N:52>'
MA3<*5VWU"*FY7D:%%%%<1L%%%% !1110 5\T?&'_ )*1?_\ 7.'_ -%BOI>O
M)_$_PCU'Q1XANM7N-<MXGG(Q&EL2$4  #.[G@=:[<!5A2J.4W96,:T7*-D>%
MV?\ Q_6__71?YU]F5XBGP%NT=77Q#"&4Y!^RGK_WU7M%H+E;2);QXWN H$CQ
M*55CZ@$G'TS6N85J=7E<'>UQ4(2C>Z)J***\TW"BBB@ HHHH *^;_C/_ ,E"
ME_Z]HOY&OI"O*O%GPHU+Q9K\VJW&M6L+.JHL:6S$*H& ,EN3[UVX&I"G4YIN
MRL95HN4;(\"K[01UD4,C!E/0J<BO$?\ A0=U_P!#!#_X"G_XJC_A0=U_T,$/
M_@*?_BJZ\54P^(M[]K>3,J:G"^A[8]Q!$VV2:-&ZX9@#6!X@\<:'X?MF,MY%
M<79.V*T@<-+(QZ# Z?4\5YE_PH.Z_P"A@A_\!3_\55_1?@A)IFN6-_/K44\5
MM.DS1"W*[]ISC.[VKE5'#+5U+_(TYJC^R>P+NV#?C=CG'3-+117";!1110 4
M444 %>+?'_\ YE[_ +>?_:5>TUP'Q ^']]XXO+1O[4@M;:T5A&A@+,2V-Q)W
M#^Z./:NG!SC"LI2=DO\ (SJIN#2+?PE_Y)CH_P#VV_\ 1SUVE<WX)\.WGA7P
M_'I%S>0W<4+,872,H0&8L0<DYY)KI*SKM2J2:V;94%:*3"N'^('PZL_&%J;F
MWV6VKQK\D^.)0/X7]O0]1^E=Q14TZDJ<N:+U'**DK,^-]1TZ\TF_FL;^W>"Y
MA;:\;C!'^(]^]?1OP>_Y)O8_]=)O_1AJ]XY\!V'C/3SO"P:E$I%O= =/]EO5
M?Y=N^5^'&CWN@>#8--U"+R[F&:4, <@C><$'N".:]#$XJ->@NCN84Z;A/R.L
MHHHKS#H"BBB@ HHHH *Y'Q[X&MO&FE!-RPZA ";:<CCW5O\ 9/Z=?8]=15PG
M*$E*.XFDU9GQYK&BZCH&H/8ZG:O;SIV8<,/53T(]Q7:?#OXFS>$_^)=J*27.
MDLV5"<O 3U*YZ@]Q^([Y^@-6T73==LS::I90W4)Z+(O*GU!Z@^XKS;5_@5I-
MR[/I6IW%EGGRY5$RCV'((_$FO56.HUH<E96.;V,X.\#T#1_%>@Z]&KZ;JEM.
M6_Y9[]KCZH<$?E6QTKP*?X$:\I_T?5--D&?^6A=/Y*:DB^!_B1XQ'<:U8K'T
M*H\CC';@J*YI8?#[QJ:>AHJD^L3U#Q%\0O#?AN%_M.H1SW('%M;$22$^AQPO
MXD5P7@7Q=?\ C?XIF\NE\JWM;*4V]NARL0+*"2>Y.1D_2I].^ MC&P;4M;GG
M&>4MXA'^I+?RKT'P[X,T'PMN;2K%8IF78\[,7D8<'&3T&0.!@<4.6&I0:A>4
MGU!*I)IO1&]1117 ;!1110 4444 %>+?'_\ YE[_ +>?_:5>TUY_X^^'^H>.
M+NU8ZI;VMM:!Q$GD%F);;DD[A_=':NG!SC"LI2=DO\C.JFX-(^;:^J?APZ-\
M/M%"L"5MP" >G)KSC_A0=U_T,$/_ ("G_P"*H_X4'=?]#!#_ . I_P#BJ]'%
M5</7BH\]ODS"G&<'>Q[;)-%%CS)$3/3<P&:S-5\4:'HELT^H:I:PJHR%,@+M
M_NJ.2?H*\E_X4'=?]#!#_P" I_\ BJ/^%!W7_0P0_P#@*?\ XJN-4,-?6I^#
M-7.ITB>PZ)J8UK1;74EA:%+I/-C1SSL/W2?<C!_'O5^H;.UCLK*WM(AB."-8
MT'LHP/Y5-7%*UW8U6P4444AA1110 5XK?>.9/!'Q=UR&Y#S:7=/$TR+U1C$A
M#J/49P?4?05[57!>+/A1H_BK4Y]4:[NK6^F"AV0AD.%"C*D>@'0BNG"SIQDU
M5V:,ZBDTN7<Z_2M9TW7+-;K3+V&ZA89S&V2/8CJ#[&K<TT5M"\T\J11(,L[L
M%51ZDGI7B3_ W6+.?S-,\0P!AP'9'B;'_ 2:AF^#?C'4' U'7[.9!T+W$TI_
M)EK7ZO0;NJFGH3SS_E.8^*?B2R\3>,3<:>WF6UM MLDHZ289F+#VRQ'X9JQ\
M*O"-SK_BBVU!XB-.L)1+)(1PSKRJ#U.<$^WU%=WHGP+TVUD676-2EO<'/DPI
MY2'V)R2?PQ7J5C86FF6<=I8V\=O;QC"1QK@"NBKC:<*7LJ.O2Y$:4G+FD6**
M**\DZ0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img5370606_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img5370606_1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $] ;\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MIVJN/='%@Y6FT=-1117O'HA1110 4444 %%%% !1110 4444 %%%% !1110
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MSKL?E:Y?H%V@7$F !C W''Z5V7PYD)TZ]BSPLH;\Q_\ 6KFO&( \47N/5?\
MT!:Z/X<H197S]C(H_('_ !KP<(N7&-+NSS:*M7MZG;4445[YZ04444 %%%%
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M-I)&5$4$LS'  '<FG5YG\<O%0\/> )K&&0+>ZL3:H,C(BQ^];!ZC;\OMO!H
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MM;VK#;&P[/)T!SD8&X@CD"O'=;_:"\8:C(PTT6>E0[LKY40EDV^C,^0?J%%
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M5KH_VB/^2;V__81B_P#0)* /EJOI_P#9Q_Y)YJ'_ &%9/_145?,%?3_[./\
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M KZ_^-O_ "2'7?\ MW_]*(Z^0* /H+]F;_4^)O\ >M?_ &K71_M$?\DWM_\
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M?=W2N9^(O_)-_$G_ &#IO_0#0!\35[_^S+_S-/\ VZ?^UJ\ KW_]F7_F:?\
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MH'YE:^WJ* /E;0/V?_%^ISC^U?LVD6X(W-+(LTA!'550D'Z,RU[WX(^'&@>
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MJ%O;WNF3S17"%XYH9%YP<,"#R",CVY'/7#ITY5)<L5J#DHJ[.THK/T;6M/\
M$&F1:AIMPL]O)W'53W5AV(]*J^%?$,?BG0(=7AMV@BF9@J.V6^5BO./<&DX2
M2;:V"Z-JBBD9E12S$!0,DD\ 5(Q:*X;_ (61'J>H7%AX5T:[UV>WQYDJ.L,
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8@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img6294127_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img6294127_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" /E!7X# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_<MK-1[JQ_\ 9JY&BL7CL0_M&;Q%5]3J&\?:TPP/LR^XC_\ KTW_ (3O6_\
MGI!_WZ%<S14?6Z_\[)]M4_F.H7Q]K(&#]F;W,9_QJ=/B'J@/SVMHP]E8?^S5
MR%%-8RNOM,?MZG<[F+XCR#_7::K>Z38_F#5^#XAZ<_$UK<QGU7:P_F*\WHK6
M.8XA=;_(M8JJNIZY;^,-#N.!?+&?212OZD8K6@N[:Z7=;W$4P]8W#?RKPVE5
MV1@R,58="#@BNB&:S7Q13-(XV75'N]%>/V?BK6K+ COI'4?PR_./UYKH;+XB
MR#"W]DK#N\#8_0_XUV4\SHR^+0WCBZ;WT._HK'L/%.CZC@17BQR'_EG-\A_7
M@_A6QUKMA.,U>+N=,9*2NF%%%%6,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>UN[>]@6>UF26)NC(<UZ]'$TZRO!G=3JPJ?"R:BBBMS0**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 4444 %<WXC\66^C*UO!MFO2/N9XC]V_PJAXI\8BT+V&FN#<?=DF'2/V'O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF/%WB4:1;?9+
M5Q]ME'4?\LU]?KZ5J:]K,.B::]R^&D/RQ1_WF_P]:\?NKF:\NI+FX<O+(VYF
M/<UYN/Q?LH^SA\3_  .3$U^1<L=R,DL2222>23WI***^?/-"NB\.^%+G6F$\
MNZ"R!YDQR_LO^-:7A?P:;K9?:FA6#K' >"_N?;V[_P _0U540(BA5 P !@ 5
MZN#R_G]^KMV.RAAN;WI[%>QT^UTVU6WM(5CC'IU)]2>YJS117N))*R/022T0
M445C^)9M0M=(>YTZ7RY(CN?Y V5[]1VZ_G4U)\D7)] E+E5S8HKRAO$^M.<G
M4)/^ @#^0J$ZYJS#!U*Z_"4BO.>:T^D6<OUN/8]=HKR'^V-4_P"@E>?]_P!O
M\:7^V-4_Z"5Y_P!_V_QI?VK#^5A];CV/7:*\F37-67&-1N>/60G^=6(_$VM1
M]+]S_O*I_F*I9I3ZQ8UBX]CU&BO.(_&6L)]Z2*3_ 'HQ_3%78O'=V/\ 76<+
M_P"XQ7^>:TCF5![W12Q--G=45RL'CFS;'GVD\9_V"&_PK3M_$^D7' NQ&?21
M2OZ]*WCBJ,MI(T56#V9KT5'%/#<+NAE21?5&!'Z5)70G?8T"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ K.U?1;/6;?RKE/G'W)%^\OT_P *T:*F48S7
M+)70FDU9GD&MZ!=Z)<;)EW0L?W<RCY6_P/M6217M]S:P7EN]O<1K)$XPRL*\
MS\2>%IM'<SP;I;)CPW=/8_XUX.,P#I>_#6/Y'G5\.X>]'8YHBDIY%(17FG(-
MHHHH ?%+)!,DL3E)$(96!Y!%>L>&/$*:Y98D(6\B&)4'?_:'L?TKR2K6G:A/
MI=_%=V[8=#T[,.X/L:Z\)BG0G?H]S:A6=.7D>W452TK4X-7T^.\MS\KCYE/5
M6[@U=KZ:,E)76QZR::N@HHHIC"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/3+>\CX$JY(]#T(_ YKQ*NZ^'NJ8>?3)&X/[V+/KT8?R/X&O2RVMR5>1[/\
M,ZL)4Y9\KZG?4445] >F%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 07MTEC8SW4GW(D+GWP.E
M>)W$\EU<RW$IS)*Y=C[DYKT7X@:A]GTF*R4_-<OEO]U>?YX_*O-:\'-*O-45
M-=#S<9.\N7L7M'TV35]4ALX\@.?G8?PJ.IKV:"".VMXX(5"QQJ%51V KE/ 6
MD?9=.?4)5Q+<\)GL@_Q/\A77UW9=0]G3YWN_R.C"T^6',]V%%%%>@=04444
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M5J'V[P[$C'+VQ,)^@Z?H0/PKHJ^MI5%4@IKJ>W"7-%2"BBBM"@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKU'P'<>=X;6//,$K)^!^;_V:O4RJ=JKCW1UX.5IM'3T445[QZ04444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&7D<-2FX,KD4PBI2*C(KE9D:_AO5/L&H"*1L03D*V?X3V-=]7DYKT+P[J/\
M:&EKO;,T7R/ZGT/XC^M>KEU?>D_D=6'G]EFM1117K'4%%%% !1110 5Y!XAM
M/L6O7L(&%\PLH]FY'\Z]?KSKQ];>7J\%P!Q+#@_4'_ BO-S.%Z*EV9RXN-X7
M[''M333S3#7@'F"5WOPXGRFH6Y/0HX'Y@_R%<%77?#V7;KD\?9[<G\0P_P#K
MUU8&7+B(FV'=JJ/2J***^G/7"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGZ+;?9=+B!&&?YV_'_ZV*T*^@PM/DI)'?3CRQ04445T%A1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5Q6KIY'Q&TN;C$J*,GU^9?\
M"NUKDO%Z>3J^A7PZ)<A6/ME3_0URXQ?NU+LT_P 3&NO=OV:.MHHHKJ-@HHHH
M **** "BBB@ K$\577V;0I5!PTQ$8_F?T!K;KB_&]SFXM;4'[JF1A]>!_(_G
M7-C)\E&3,JTN6#.66I!4:U(*^;/.0\4\=:C%2"J12'BI!48J052&AXKN=$M_
MLVE0@C#.-[?C_P#6Q7&6<!N;N* ?QL!^%>A !0 !@#@"O4RZ&KF=6'6[%HHH
MKU3I"BBB@ HHHH **** "BBB@ K,\10^?X=OTQG$+/\ ]\\_TK3J*YB\^UEA
M/\:%?S&*<79I@>([J=#.]O/'-&</&P=3[@Y%0YI,UZYB>YVMPEW:0W$?W)4#
MCZ$9J6N;\#WOVKPY'&3EK=VB/TZC]#C\*Z2O)G'EDT:H****D84444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"\GF^%-(?))^QQ D^H0 UK5\_)6DT=2V"BBBI&%%%% !1110 4444 %%%!(
M))P!WH CFFCMX'FF<)&@+,QZ 5Y-XBUR36]0,O*V\>5A0]AZGW-:?BWQ+_:<
MILK1_P#0XS\S#_EJW^ _^O7)DUX./Q?M'[.&R_$\W$U^9\L=@)IM%%>6<@ $
MG Y->K^$M!_L;3=\RXNYP&DS_".R_P"/O7->"/#WVNX&J72?N(C^Y4C[[#O]
M!_/Z5Z-7MY;A;+VTOE_F=^$HV]]A1117KG<%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZC_/->YA\QA4TGH_P/0I8F,M):,ZRBFQR)+&LD;JZ,,AE.0?QIU>B=04444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8Y)IE%>'4JSJ.\W<X93E+XF+FDHHK,D**GM+*ZOYQ#:0/-(>R#./KZ5VVC>
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M7J5[2RM;" 0VD"0QCL@QGZ^M6***]!))61U)6V"BBBF 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %<1\6-7_LKP%>(K8EO&6V
M3Z-RW_CH8?C7;UX5\<]9\_6K#1XV^6UB,T@'3>_0'W &?^!5TX.GSUHKYF=6
M7+!GE.:3--S1FOI#@'9I,TW-&: '9KZ ^"&G_9_"%U>LN&N[HX/JJ@ ?KNKY
M\S7UCX)TS^Q_!6D617:Z6RNX]';YF_5C7G9E.U)1[LWPZO*YOT445X9V!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBBB@ KZ(_9HLY$T[Q%>D'RII8(E..Z!R?_1@KYYBB>:5(HD9Y'8*JJ,EB>@
MK[0^&OA0^#? UCIDJ@7; SW6#G]ZW)'X#"_\!H ZVBBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKXKV)I6KPM<-_P NTI\N7_OEN3^&1744 %%%% !1110 4444 %%%% !1110
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M0;F_X#78U\Q?M">*?[3\66^@P29M],3,H!X,S@$_DNT?4F@#QVBBB@ HHHH
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MPQI:PIR!=7OS-]0@.!^)/TKR37O&?B3Q.Y.L:Q=72$Y\HOMC'T084?E6%10
M4444 %%%% !1110 4444 %%%% !1110 5T_A3X@^)?!LP.DZ@XM\Y:TF^>%_
M^ GI]1@^]<Q10!]8> OC5HGBUXK#4%72]6;"K&[9BF/^PW8G^Z?P)KT^O@"O
M<?A3\:9K"6#0?%5R9+)L);W\ART)Z!9#W7_:ZCOQT /HZBD!#*&4@@C(([TM
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% &9XBUNW\.>'=0UBZQY5I"TNW.-Q ^5?J3@?C7PYJ%]<:IJ5U?W;[[BY
ME::5O5F.3^IKW_\ :,\4^38Z?X7MY/FG/VJZ /\  #A!^+;C_P !%?.] !11
M10 5-9VD]_?6]G;1F2XN)%BB0=69C@#\S4->L_ #PQ_;'C=]7FCW6VDQ^8,C
M@S-D)^0W'Z@4 ?2/AK0X/#7AK3M&M\>7:0+&6 ^\W\3?BQ)_&M6BB@ HHHH
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MQ[V0++?39CL[<G_6/ZG_ &1U/X#O7QWJVJWNN:K<ZGJ-PT]W<.7DD;N?Z =
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9--';P23S.J11J7=V.
MH R2:?7E_P =O%7]@>!'T^"3;>:LQMUQU$0YD/Y87_@= 'S?XU\22>+/&&I:
MRY;9/*?)4_PQCA!_WR!^.:P*** "BBB@ K[ ^#GAC_A&?AY8B6/;=W_^F3YZ
MC>!M'X+MX]<U\T?#KPR?%OCK3=+="UL9/-N<=HEY;\_N_4BOM8    8 Z 4
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M_9N_Y'+5O^P?_P"U$H ^F**** "OF#]H[_DH>G_]@J/_ -&RU]/U\P?M'?\
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M9=1\06$4B]8EE#N/^ +EOTKY!UOQMXF\1;AJVN7MS&W6(R%8_P#OA<+^E8-
M'U/J?[0O@VS++9QZAJ#=FBA"*?Q<@_I7)7_[2UPV5T[PU$GH]Q=%\_\  54?
MSKP6B@#U:]_:$\:W)/D+IMH.WE6Y8C_OMC6%=?&/Q_=YW^(ID'I%#%'C_OE1
M7#44 ='/X_\ &-SGS?%&L8(((6]D4$'V!K/E\1Z[,P:76M1D(& 6NG/]:S**
M +!O[PYS=SG/7,AJO110 4444 %%%% !5BP_Y"%M_P!=5_F*KU8L/^0A;?\
M75?YB@#[WHHHH ^</VD]5,OB#1M)5OEM[9KA@/5VVC/X1_K[UX?7H7QNO3>?
M%?5AG*6XBA7\(U)_4FO/: "BBB@ K8\*Z1_;_BS2=)P=MU=1QOCLA8;C^ R:
MQZ].^ FGB]^*-M,5R+.VFGY[<;/_ &>@#ZP551 B*%51@ #  I:** "BBB@
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M?U27)R?,O)&R?Q-9%% %N35-0F;=+?7+MC&6F8G^=5I)'E<O([.Q[L<FFT4
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M'P#]1@^] 'R5177^,OAKXC\$REM1M/-LBV$O8,M$?3)ZJ?8X]LUR% !1110
M4444 %%%%  "000<$=#7VG\-O% \7>!-.U)W#72IY%USD^:G!)^O#?\  A7Q
M97L_[//BK^S_ !+=>';B3$&HIYD /03(,X'U7/\ WR* /IBBBB@ HHHH *^?
M_P!IK_F5O^WO_P!HU] 5\_\ [37_ #*W_;W_ .T: / **** "BBB@#KOA:JO
M\3_#P8 C[8IY]0"17VC7QA\*_P#DJ'A[_K['\C7V?0 4444 %%%% !1110 5
MYW\<9C#\)M65>/,>!,Y[>:A_I7HE>8?'W_DET_\ U]P_S- 'R?1110 4444
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M?4)+'3$/599?,D'X)D?^/4 >345](Z;^S9HT0!U/7;ZY;N+>-(1].=U=39?
M[P#9@;])DNF'\4]U(?T4@?I0!\BT5]LVWP[\&6F/*\+Z3D=#):HY'XL#6K!H
M&C6N/L^D6$6#D>7;(N/R% 'PC4D5O--GRH9),==BDXK[XCACA7;%&D:DYPJ@
M#-/H ^!S8W8!)M9P!U)C-05]_P!?!%__ ,A"Y_ZZM_,T 5Z*** "BBB@#ZW^
M!7_)*--_ZZS_ /HQJ](KS?X%?\DHTW_KK/\ ^C&KTB@ HHHH **** "BBB@
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MYA['L?4'D?3!H YBBBB@ HHHH *MZ9J-SI&JVFI6C[+FUE6:-O1E.1^%5**
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M ?8U%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\<?&#_ )*OK_\
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M?^NK?S- %>BBB@ HHHH ^M_@5_R2C3?^NL__ *,:O2*\W^!7_)*--_ZZS_\
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M=_R4/3_^P5'_ .C9: /'Z*** "BBB@#TCX%?\E7TW_KE/_Z+:OK>ODCX%?\
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MHHHH **** /K?X%?\DHTW_KK/_Z,:O2*\W^!7_)*--_ZZS_^C&KTB@ HHHH
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MO^WO_P!HU] 5\_\ [31&[PNN1D"[)'_?F@#P"BBB@ HHHH [#X5_\E0\/?\
M7V/Y&OL^OC#X5_\ )4/#W_7V/Y&OL^@ HHHH **** "BBB@ HHHH XCXK>$3
MXP\"7=K!'NOK;_2;7 Y+J#E1_O*2/J1Z5\;]#7W_ %\J_'#P&WAGQ,VLV4.-
M+U-R_P HXAFZLOL#RP_$=J /*J*** "BBB@#JOA_XVN_ OB:+4H0TEJ^([NW
M!_UL>><?[0Z@_P!":^Q]'UBPU[2;?4],N$N+2X7<CK^H/H1T([&O@ZN[^&_Q
M.U'P%?\ EG==:/,^;BTSR#TWIGHWZ'&#V( /L2BLO0/$.E>)])CU+2+M+FV?
MC*_>0]U8=5/L:U* "BBB@ HHHH **** "BBB@ HHHH **** "O@*1VED:1SE
MF)8GU)K[]KX.UNR.FZ]J-BR[3;74L)&,8VL1_2@"C1110 4444 ?3W[.#J?
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MZ$ 'V'1532]4LM:TV#4=.N4N+2X7?'*AX(_H>Q'4&K= !1110 4444 %%%%
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M^Z39<6TK0RKZ,I(/ZBOO:OF#]H/PO_97BZ#7($Q;ZI'^\P.!,@ /YKM/N<T
M>/T444 %%%% 'M?[._BK[#X@N_#<\F(=07SK<$\"9!R!]4S_ -\"OI2O@S2=
M3N=%U>SU.T;;<6DRS1GME3GGVK[ET75K;7=$LM5LVS;W<*S)Z@$9P?<=#]*
M+U?._P"TO_R$?#O_ %RG_FE?1%?._P"TO_R$?#O_ %RG_FE 'A%%%% !1110
M!V'PK_Y*AX>_Z^Q_(U]GU\8?"O\ Y*AX>_Z^Q_(U]GT %%%% !1110 4444
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MR3\<= ;1?B3=W"IBWU)%NHSVR1AQ]=P)_$5]7:?>PZEIMK?VYS#<PI-&?56
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M 'R3FMN*:*=-\,B2+G&48$?I0 ^BD)"J68@ #))[5EWOB?0--!-]K>G6V/\
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M?HHHH **** /2/@5_P E7TW_ *Y3_P#HMJ^MZ^2/@5_R5?3?^N4__HMJ^MZ
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MV,?]\FOH>B@#C_"GPQ\+>#9EN=+L&:]52OVNXD+R8/!QV''H!78444 %%%%
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MPW20LHWJRD<D8Z;J^EJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3^-/#-M.\$^NV$4L;%71Y@&4CJ"#TJHQE+97$VEN;M%<]_PG?A3_ *&'3O\
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MZL@]%FCQ^J5-X>^%<7A3QA9ZMIFH2RVBK(DL-QC>,J0""H /..,"O1B0H))
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M^/ZW_P"NB_SK[,KXSL_^/ZW_ .NB_P Z^S*US7>'S_0G#=0HHHKR3I"BBB@
MHHHH *^;_C/_ ,E"E_Z]HOY&OI"OF_XS_P#)0I?^O:+^1KT,M_C?(PQ'P'GM
M>Q?\(#\4O^AGF_\ !K-_A7CM?:5=N/KRI<O*EK??Y&5&"E>YXKI_@KQ_9^(=
M'N]8U.;4;&"^B>1/MSR[!N'S;6]/:O:J**\BM6E5LY+8ZHP4=@HHHK$H****
M "BBB@ KQ;X__P#,O?\ ;S_[2KVFO%OC_P#\R]_V\_\ M*NS ?[Q'Y_DS*M\
M#.U^$O\ R3'1_P#MM_Z.>L#XD_"V/6Q)K&A1)'J0!:: <+<=\CT?^=;_ ,)?
M^28Z/_VV_P#1SUVE3.K*EB)2CW?YC45*"3/B^2-XI&CD1DD0E65A@J1U!%=3
MX(\=ZAX,U#='NGT^4_O[0M@-_M+Z-[]^AKV+XC?#.#Q1%)J>F*L.L(O(Z+<
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MZ\)2:LBE\!_^1IU+_KR_]G6O:]4\0:1HL32:EJ5K;!1G$D@#'Z+U/X"O(?\
MA0=U_P!#!#_X"G_XJC_A0=U_T,$/_@*?_BJ*ZPU:ISNI^#%#VD(VY3E_B;XY
MB\8ZM!'8HRZ=9AA$SC#2,V,L1V' P/\ ' XRRLKG4;V&SLX'GN9F"1QH,EC7
MMMC\!+"-P;_7+F=<_=@A6+]26KT#P[X-T+PM&1I=BL<K##SN=\C?\"/0>PP*
MV^O4*,.2EK8GV,Y.\@\&: ?#/A*PTIV#31(6E(.1O8EFQ[ G'X5O445X\I.4
MG)[LZDK*R"BBBI&%%%% !1145R)S;2"V:-9RIV-("5!]2!U% 'Q_K'_(;O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img6294127_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img6294127_1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $] ;\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MIVJN/='%@Y6FT=-1117O'HA1110 4444 %%%% !1110 4444 %%%% !1110
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MSKL?E:Y?H%V@7$F !C W''Z5V7PYD)TZ]BSPLH;\Q_\ 6KFO&( \47N/5?\
MT!:Z/X<H197S]C(H_('_ !KP<(N7&-+NSS:*M7MZG;4445[YZ04444 %%%%
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M-I)&5$4$LS'  '<FG5YG\<O%0\/> )K&&0+>ZL3:H,C(BQ^];!ZC;\OMO!H
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MM;VK#;&P[/)T!SD8&X@CD"O'=;_:"\8:C(PTT6>E0[LKY40EDV^C,^0?J%%
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M5KH_VB/^2;V__81B_P#0)* /EJOI_P#9Q_Y)YJ'_ &%9/_145?,%?3_[./\
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M KZ_^-O_ "2'7?\ MW_]*(Z^0* /H+]F;_4^)O\ >M?_ &K71_M$?\DWM_\
ML(Q?^@25SG[,W^I\3?[UK_[5KH_VB/\ DF]O_P!A&+_T"2@#Y:KZ?_9Q_P"2
M>:A_V%9/_145?,%?3_[./_)/-0_["LG_ **BH ]@KA?&GQ9\,^"G>UN)VO=2
M4?\ 'G:X9D.#C>W1.W'7D'!KG/C?\1[GPKI\.A:/.T.JWT?F23J"&@@R1E3T
M#,0P!'( )X.TU\O,Q=BS$EB<DD\DT >N:]^T-XJU!W32+>STF$L"C!//E''(
M+.-I!//W!V_'A[_XA^,=2FDEN?$VJYD^\D5RT:?]\*0H_ 5Z1\-O@7_;MA;:
MWXFFDALIU66WLX3AY5."&=OX5([#D@YRM>X:/X"\)Z L0TWP_80O$24F:(22
MC/\ TT;+?K0!\5@7VIS' N+N7J?O2-5B3P_K4,#SRZ1?QPH"7D:V<*H]2<8%
M?=W2N9^(O_)-_$G_ &#IO_0#0!\35[_^S+_S-/\ VZ?^UJ\ KW_]F7_F:?\
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MH'YE:^WJ* /E;0/V?_%^ISC^U?LVD6X(W-+(LTA!'550D'Z,RU[WX(^'&@>
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MJ%O;WNF3S17"%XYH9%YP<,"#R",CVY'/7#ITY5)<L5J#DHJ[.THK/T;6M/\
M$&F1:AIMPL]O)W'53W5AV(]*J^%?$,?BG0(=7AMV@BF9@J.V6^5BO./<&DX2
M2;:V"Z-JBBD9E12S$!0,DD\ 5(Q:*X;_ (61'J>H7%AX5T:[UV>WQYDJ.L,
M_P"VC?0XXYQQFKL'BS5K>[MH-<\*W=@ES.L$<\%Q'<QAF( WD8*C) Y%;.A4
M6Z_%7^[<GG1UE%%%8E!17&>)?B#%X<\3V>@G2YKNZO%C,!BE50Q=R@!W8P=P
M/MTK8T_6-7N;](+WPW=64+ _Z0US#(H.,X(5B>W7%:.E-14GL_0GF5[&W111
M69045QTGCF>^U;4-,\-Z'+JT^G2>7=N]PEO&C<C +9+'*L.F..N*V] UB;6;
M2=[K3+C3KFWG,$T$Q#88*K95APRX88/>M)4I15W_ %\B5)/8UJ***S*"BBB@
M HHHH **** "BBB@ HHHH *RO$__ "*>L_\ 7C/_ .BVK5JMJ%E'J.FW5C*[
MI'<PO"S)C< P()&01GGTJHNTDQ/8\(^%>FZWJN@>(K71M6AT]Y/*5F>W+LV0
M_ ;=\G<9VD\\8(KJ?@[KEA%]L\*Q:<]M>6V^>:;S_-69@P1CT&W'R@ 9&!GK
MUV]-^%>GZ-:W%MIFOZ_:1W!4R^1<1HS%<X^81Y'4]#6UX7\$:'X11_[+MF$\
MBA9+B5]\CC.<9Z >P S@9Z5WU\13FI^=K?\ !,84Y*QT5%%%><;GBWPZ_P"2
MV^*_^WS_ -*4KVFN6T3P%IF@^)[[Q!;75[)>7OF>:LKH4^=PYP H(Y [UU-=
M&)J1J33CV1%.+BK,*\%TEI;7]HB8ZJY61KN<1-*_\+1MY0S[J5 'N!7O5<_X
ME\%Z'XK53J=KFXC7;'<Q-LE09SP>XY/!R.31AZL:?,I;-6%.+E9KH;LLD<4+
MR3.B1(I9V<@*%'4DGM7A7P)6Z/B;5GB\P6 M<2#/R[RXV9]\"3'XUZ3=^ 4U
M#3TT^^\2^(;FS7[T4ES'^\'H[",,P^IK?T;1--\/Z>MCI5HEK;!BVQ<DECU)
M)R2>@R3T ':JC4A3I2@M7('%RDGV-"D;&P[ONXY^E+2$ @@]#7*:'B]U\/O%
MW@U[C4/!.M-/9L#)]FR-Y'^Z04<@=^#Z"NQ^&GCB?QGI-TU[;I%>VCJLC1*0
MCA@=I&>AX((^A[X%N'P(MMI3Z7;^)=?BL6&T1">([%QC:K&,LHP,8!K:T#P_
MIOAG2DT[2[?RH%.YB3EG8]68]R<#^0P!BNRK7C.#4M9=':WWF48-/38TZYWQ
MY'>R^!-:CT\$W#6K# &24_C ]RNZNBHKEA+EDI=C1JZL>5? B6U;PMJ,*%/M
M:WFZ4?Q;"B["?;(?'XUZF[HB@NRJ,@98XY)P!^>*Y&Z^&VAOJO\ :>FRWVBW
M9^^^F3"(..."I!&.!P  >^:MGP;#<:C:WFI:QJVHFUD66&&XG58ED4Y5]L:J
M"0?7-;UI4ZDW-/<B"E%6L=+1117,:'A_Q1_Y+!X;_P"N5K_Z4/7N%<IX@^'^
ME^)/$5GK=U=7T5W:*BQ"!T"?(Y<$AE/<GO75UTUJL9PA%=$9PBTVV%>3_'G_
M )%S2_\ K[/_ * :]8KG?%W@W3_&=I;VVHW%W%'!(9%^SLJDDC'.Y34X:HJ=
M52ELAU(N46D97@32M=AT70[N?Q(UQI[6,3"P-E&H53&-J[Q\WR\<]\5V]<K'
MX)>'38=/A\4^((K:&(0QK%+"A5 , !A%G@#KFNHCC2*)(T&U$ 51Z 5-:2E+
MF3_"PXJRL.KB/$VG6>K>/M$L+^W2XM9["[62-QP1^[_(@\@CD$ BNWK,N-#@
MN?$-EK+SSB>TBDBCB4KY9#]2>,YX'?M2I2Y97\G^025U8\9O]*U_X.Z__:FE
MM)>Z!.P61'/#+GA),?=8?PN!_,K7H/PA_P"2:Z;_ +\W_HUJ[2XMX;NWDM[B
M))89%*O'(H96!Z@@]15#0="L_#FE+IMAO%K'([QJ[;BH9BVW/<#.!GG'7/6M
MZN)]K2M)>]IKWM<B-/EE=;&G7+?$A+V3X>:TMAO\_P C)VG!\O</,_\ '-U=
M317-"7+)2[&C5U8\P^!D]JW@R[@B9?M$=ZS3)N!;E5VMCJ 0,#W4UZ7,\*1@
MSM&J;U ,A &XL HY[[L8]\5R,WPST-=6_M/2I]0T6Y;[YTR<1*XR#@J01C('
M P..E73X+M[C4K:^U/5M6U)K61)8(KF=5B213E7V1JH+#U.:WK2IU)N:>Y$5
M**M8Z6BBBN8T/$/BA'--\8O#45O<&WG>.U6.8(&\MC</AL'@X/.#7J^A:;K&
MGFX_M;7VU4/M\K=:1P^5C.?N=<Y'7ICWK*\0_#[3?$?B&UUNXO\ 4;>\M518
M3;/& FQBRGYD/.235V/PQ*+ZWN;CQ%K5TL$@D$$DL:1N1TW!(U)&><9QD"NR
MI5C.G&*>R[&48M2;.@HHHKC-3R36?AWXCT[7+OQ%X*UDHUW(UP]JS;"Q8YVC
M(V.,DX# 8XZ]:U_ACXXU3Q,U_I>MVX34+#:&D5"A;DJP=>@8$=L#GH,<[X\'
MF&6^-IXBUNTBO)7E>&*:(HC.Q9MFZ,E,EB>"*L^&?">E>$[*2WTV)]TK;IIY
M6W22GL6/MD\# Y/')KLG6C*FXRU>EG;7YF2@U*ZV-RBBBN,U"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
8@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>rkda-20240702.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-08-23T11:32:54.2168+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://arcadiabio.com/20240702" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:rkda="http://arcadiabio.com/20240702" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="rkda-20240702.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentDescription" order="10450.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140335290319568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 02, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul.  02,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Arcadia Biosciences, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001469443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-0571538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5950 Sherry Lane<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dallas<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">974-8921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RKDA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">On July 8, 2024, Arcadia Biosciences, Inc. (the &#8220;Company&#8221;) filed a Current Report on Form 8-K (&#8220;Original Form 8-K&#8221;) to report, among other things, the appointment of Thomas J. Schaefer as the Company&#8217;s chief executive officer and Mark Kawakami as the Company&#8217;s chief financial officer, effective July 5, 2024 (&#8220;Effective Date&#8221;).  The Company is filing this Form 8-K/A to amend the Original Form 8-K to disclose new compensation information for Mr. Schaefer and Mr. Kawakami in connection with their appointments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M3?G:'1:W8\7SWZSZ" CC/.BB'0=K2L^T1\XGS$UUP?2+Z]SK2)@P48:#Y"O
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MP %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ %E\769>*NQS     $P(
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M,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04
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MYHOA/UY_ 5!+ 0(4 Q0    ( !9?%UD'04UB@0   +$    0
M  "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ %E\764.;?QWO
M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ %E\769E<G",0!@  G"<  !,              ( !S0$  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  67Q=9:&+QH'H%  #4$P
M&               @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ %E\769^@&_"Q @  X@P   T              ( !O@T  'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    "  67Q=9EXJ[',     3 @  "P
M        @ &:$   7W)E;',O+G)E;'-02P$"% ,4    "  67Q=9.JJBYT !
M   \ @  #P              @ &#$0  >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ %E\7620>FZ*M    ^ $  !H              ( !\!(  'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ %E\76660>9(9 0
MSP,  !,              ( !U1,  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2      D "0 ^ @  'Q4

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="rkda-20240702.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K/A" isOnlyDei="true" isUsgaap="true" original="rkda-20240702.htm">rkda-20240702.htm</File>
    <File>rkda-20240702.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "rkda-20240702.htm": {
   "nsprefix": "rkda",
   "nsuri": "http://arcadiabio.com/20240702",
   "dts": {
    "inline": {
     "local": [
      "rkda-20240702.htm"
     ]
    },
    "schema": {
     "local": [
      "rkda-20240702.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_58bd9847-8f56-4853-b412-803a645ebfd6",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rkda-20240702.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_58bd9847-8f56-4853-b412-803a645ebfd6",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rkda-20240702.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://arcadiabio.com/20240702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0000950170-24-100065-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-24-100065-xbrl.zip
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M"+:"L9-$Q/&(?)8)2T+)8G)>#WH(LPP;I!W'Y Q;Y>1,Y"*[$KQ1]MDK !P
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M/=_0UQ7KNQ,&VR$,?A8!\-S^K^="ZBV+9?V<9D#PY$0%LV:D^EI9#(=$1AC
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M>> ^V8E2*DXCW0B4T%D=398ZMD'+39-=1.::&,H6XJ?N!B:S(I^&?A0"?NJ
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M8):72=XJ&#Z.'OMT\[-&2\T\DO/ZH-S,F^1;^^P+^=+^5_M+^UOW5?.P;10
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MR>[^Z9R?'AVUQ'L*\>ZX_\8Y/>X?GI^>'9[WS\];ZCV!>@\/#STF\V1#$?9
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M"'=Q=K$:[6(7F>'CI]_ #/_QYO;F^T^W-UTEZ[,N$BVTIVF2@O'EAO<\8*
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M_:3: DZ+I,HZ"(A73)'U< M+.K</K*':5'G=L4>#UT?,>:U))BK#W<^7+\
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M<^$.I0A>^VVRK_*$#BRDLB(>W$KH-*KW$J,E:>'G@*<12TD<JV+5C&T_8O(
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M<_:DLY! 0F(!]V,1R+08SC!-VN)&$H12$L3.F <\PO1YQY:G"V(4)(8:4\]
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M?3PW]:&UL+1Z3HL:^!P^J$7//H>N_<W2=:GY>-3K#PI5EF>]R\OS51;EL4P
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M=!RA*(%#B=D-+B?V%\<,!3ELNCL"D01BWF!FU*@^G1B;12#]D=@=E/4.1\T
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MAW KS"GO*!V^/8EXG1,&_SD,T63[!*<K>/S/3L3\Z"3BH3M^A@%P?GW>L[[
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M1C#;M#_GP AZ+K%Z?,'-5B_F" 12R"? 8&3%4BC+2825"L\T5R$PG4#.3PB
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M<NQ>)/>S:Y4'@HE-MH,H7OU8&G]#N>C ]^7MR-"78T32K2>^FLT%:/G2]E>
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M7_[]NV^G\<S[R_\'4$L! A0#%     @ %E\760_)$C#3&   ^,D  !$
M         ( !     ')K9&$M,C R-# W,#(N:'1M4$L! A0#%     @ %E\7
M620_C=:J"   K60  !$              ( ! AD  ')K9&$M,C R-# W,#(N
M>'-D4$L! A0#%     @ %E\76<T+[U(Y3P  :X@#  \              ( !
MVR$  ')K9&$M97@Q,%\Q+FAT;5!+ 0(4 Q0    ( !9?%UF)%J@+L4T  .-B
M P /              "  4%Q  !R:V1A+65X,3!?,BYH=&U02P4&      0
,! #X    '[\

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>rkda-20240702_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rkda-20240702.xsd" xlink:type="simple"/>
    <context id="C_58bd9847-8f56-4853-b412-803a645ebfd6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001469443</identifier>
        </entity>
        <period>
            <startDate>2024-07-02</startDate>
            <endDate>2024-07-02</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_781c6cc3-d85e-4dee-a71c-5d3f4c44b185">0001469443</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_71c7ccda-c00a-48c7-a360-be29af2701e4">true</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_c684eee7-1c24-4a08-b14f-1fbd6bf39fcd">8-K/A</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_297a0114-b3b9-464b-871b-d9ce87775838">2024-07-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_3899828b-edb2-4bab-bde3-5d2994278a8c">Arcadia Biosciences, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_bb860665-a4c0-41c6-bec5-b24f54894f40">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_135604ac-9352-49b9-aaf2-102d90fd3201">001-37383</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_0299b415-ecb2-43b0-93ff-72bcf58f9301">81-0571538</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_6cf74e26-d5b4-45cf-9278-d454400b2888">5950 Sherry Lane</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_26f7b18d-bcdd-4a2e-bf06-25640a727b35">Suite 215</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_9ff841ca-d852-4d75-b71e-7cd932c19795">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_5f9dda79-d010-4490-9cc6-78222e123713">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_6a6d766f-eb0a-42df-b0ba-a85fc060fb86">75225</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_ef7d22aa-988b-4112-975f-2513c0ce4182">214</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_ff76eeb3-80f9-47f6-8842-64b9dc576431">974-8921</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_03937203-09c9-4260-b869-4c0cf6f58631">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_481e5f9d-3a45-449f-b64d-3e3b1d2ac87d">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_6f7653e9-0d5e-4cd4-b823-a3cac8c31dc0">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_47d0094b-32bf-447d-b4d6-38608c749273">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_00e8ed8e-489d-426d-bf1e-c2a35ec4ddb7">Common</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_17b3a4f9-c9fc-421d-b7bb-8a56aba6822d">RKDA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_562d0bbd-6ed5-46e6-8b1a-2d4c9039d607">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_c62bcb26-536b-499d-8dac-0ad30cad5c70">false</dei:EntityEmergingGrowthCompany>
    <dei:AmendmentDescription
      contextRef="C_58bd9847-8f56-4853-b412-803a645ebfd6"
      id="F_71215fe3-c58a-48d1-af60-b4d3da539c3b">On July 8, 2024, Arcadia Biosciences, Inc. (the &#x201c;Company&#x201d;) filed a Current Report on Form 8-K (&#x201c;Original Form 8-K&#x201d;) to report, among other things, the appointment of Thomas J. Schaefer as the Company&#x2019;s chief executive officer and Mark Kawakami as the Company&#x2019;s chief financial officer, effective July 5, 2024 (&#x201c;Effective Date&#x201d;).  The Company is filing this Form 8-K/A to amend the Original Form 8-K to disclose new compensation information for Mr. Schaefer and Mr. Kawakami in connection with their appointments.</dei:AmendmentDescription>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
